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Abstract 
Systematic evaluation of the factors affecting LC-MS detection of some saponins 
and sapogenins associated with hepatogenous photo-sensitisation diseases in 
livestock, as determined using a Thermo Finnigan LCQ Advantage mass 
spectrometer, showed that ion responses could be substantially improved by 
careful selection of analysis parameters. Eluent composition, capillary 
temperatures and flow rate were found to significantly affect the ionisation of the 
target analytes.  
Optimisation of ionisation conditions resulted in a more than 100 fold (2 orders of 
magnitude) improvement in the detection of the model sapogenins and sapogenin 
glycosides relative to conditions utilised in previous studies at the University of 
Waikato. Optimal ESI and APCI responses were achieved using formic acid 
buffered acetonitrile-water eluent mixtures which possessed 30-40% acetonitrile 
for sapogenin glycosides or 50-60% acetonitrile for sapogenins and capillary 
interface temperatures in the range 275-325°C. Lower eluent flow rates also 
results in increased detector responses. Optimised ESI responses were greater by 
ca 2-10 times when compared to optimised APCI responses. 
Analyses of full scan and MS
n
 ESI and APCI mass spectral fragmentation data 
showed that the molecular weight of conjugated sapogenin glycosides could be 
readily determined from [M+H]
+
 ions observed in full scan spectra. Under MS
2
 
conditions sapogenin glycosides [M+H]
+
 ions fragmented to afford ions 
attributable to the protonated parent sapogenin and a series of other ions that were 
found to present in the ESI and APCI mass spectra of parent sapogenins, 
including m/z 399, m/z 273 and m/z 255 ions. 
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Detailed analysis of full scan, MS
2
 and MS
3
 ESI and APCI fragmentation and 
chromatographic data determined for sarsasapogenin, episarsasapogenin, 
smilagenin, 20,20,23-
2
H3-sarsasapogenin and 2,2,4,4-
2
H4–episarsasapogenin, 
tigogenin and diosgenin showed that, unlike previously reported EI-GC-MS data, 
neither LC-MS ion ratio data, or retention time data could not be used to 
distinguish isomeric 3α/β, 5 α/β, 25(R/S)-spirostanol sapogenins of the type 
known to be present in the rumen and other GI tracts samples recovered from 
livestock suffering hepatogenous photo-sensitisation diseases. 
Based on the results reported in this thesis it is apparent that a combination of EI-
GC-MS and LC-ESI-MS
n
 data will be required to identify conjugated sapogenins 
present in rumen and other GI tract samples recovered from livestock suffering 
from hepatogenous photo-sensitisation diseases since LC-MS
n
 data alone is not 
capable of distinguishing isomeric forms of free and conjugated sapogenins.  
It has been hypothesised that genetic factors may influence the nature of 
conjugates in the rumen and their metabolism to alternate conjugated analogues. 
The availability of combination of EI-GC-MS and optimised LC-MS methods to 
probe the nature and distribution of free and conjugated sapogenins in rumen and 
GI tact samples may assist in the identification of susceptible and resistant 
animals.  
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1 Introduction 
1.1 The Need for Techniques for Determining Saponins 
Steroidal and triterpenoidal compounds and their conjugated analogues are a 
widely distributed group of naturally occurring compounds. The polycyclic ring 
structure of the aglycone part of these compounds are derived by cyclisation of 
squalene
1-3
 (Figure 1.1), and (in the case of steroids) the subsequent loss of some 
of the angular methyl groups. In some cases (eg androstanes, pregnanes, etc) the 
shortening or the complete loss of the 8-carbon side chain attached to ring D 
occurs
4, 5
. Conjugated analogues of steroids and triterpenoids include compounds 
where a functional group, often a glycoside, is attached (conjugated) to the steroid 
or triterpenoid aglycone. 
O
HO
cyclization and 1,2 shifts H or  Me shifts
H
+
 
Figure 1.1. Cyclisation of squalene epoxide to afford lanosterol 
Steroidal and triterpenoidal compounds frequently possess significant biological 
activity
6, 7
. Interest in detecting and quantifying these compounds include 
applications covering medicine, toxicology, environmental contaminant 
modelling
8
, and organic geo-chronological dating
9, 10
. 
Asparagoside A or sarsasapogenin-β-D-glucoside (Figure 1.2) has been identified 
as a bioactive constituent of Asparagus officinalis
11
. More highly glycosylated 
sarsasapogenin-β-D-glucosides have been implicated as causative agents in the 
development of some livestock photo-sensitisation
12-15
. 
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Figure 1.2. Structure of sarsasapogenin-β-D-glucoside 
Many of the methodologies employed to detect conjugated steroidal and 
triterpenoidal compounds such sarsasapogenin analogues have significant 
limitations, particularly gas chromatography (GC) based methods. This is 
especially evident with conjugated analogues
8
. Some of these limitations can be 
mitigated using liquid chromatography mass spectrometry (LC-MS) based 
methodologies. 
 Steroids and triterpenoids are relatively non-polar compounds, so are not soluble 
in the polar aqueous mediums used by higher organisms to transport metabolites 
around the organism. The solubility of the relatively non-polar steroids and 
triterpenoids in these mediums are often improved by conjugation with a polar 
entity through metabolic processes. Functional groups typically conjugated to the 
steroids or triterpenoids are glycoside, sulfate, or fatty acid entities. Many 
biological processes involve attachment of conjugated groups to aid transportation 
of these compounds within the organism
8
. 
1.1.1 Analysis of Steroids and Triterpenoids using GC-MS 
Commercial GC-MS instrumentation has been available for more than three 
decades during which time a variety of analytical procedures have been 
developed. Historically analytical methods for determining the levels of steroidal 
and triterpenoidal compounds (genins) and their conjugated analogues have 
generally relied on the use of GC-MS to determine the level of parent genins 
derived via hydrolysed of the conjugated analogues
8, 16
. The best attributes of GC-
MS are the ability to allow; 
O
O
O
H
O
HO
HO
HO
HOH2C
3 
 
(i) unequivocal identification of substances from a combination of retention 
time and mass spectral fragmentation pattern data. 
(ii) quantitative determination of analytes due to proportionality between the 
fragment ion response and the quantity of analyte entering the mass 
spectrometer. 
GC-MS has some significant limitations; the most important of which is the need 
for chemical derivatisation of polar genins to more volatile and thermally stable 
analogues prior to GC-MS analyses. Genins possessing relatively polar conjugate 
groups such as glycoside or sulfate residues are not volatile enough for direct 
analysis by GC-MS
8
. Another disadvantage of GC-MS analysis is that it involves 
exposing the analyte to elevated temperatures (typically 250-300
o
C) for prolonged 
periods of time as the analyte is eluted through the GC column. This can result in 
thermally induced structural modifications to the analyte. 
The derivatisation reactions used to remove conjugate groups are often incomplete 
and can result in underestimation of the concentration of the conjugated steroidal 
or triterpenoidal compounds
8
. Conjugate groups can be removed from steroids or 
triterpenes by either enzymatic or chemical reactions
8
. Chemical reactions used to 
remove conjugates groups include acid and base hydrolysis.  
1.1.1.1 Reactions used to Modify Structures for Analysis by GC-MS 
Acid Hydrolysis 
Saponins (steroidal and triterpenoidal glycosides) can be converted to sapogenins 
by mild acid hydrolysis (Figure 1.3). GC-MS analysis of saponins or steroidal 
compounds are achieved by firstly hydrolysing the parent compound under mildly 
acidic conditions (0.5 molar HCl at 85-90°C, 30-60 min), followed by isolation of 
the parent sapogenin or steroidal compound(s) and hydrolysed sugar residues, 
followed by derivatisation of these compounds with reagents such as 
trimethylsilylchloride or trimethylsilylimdazole, acetic anhydride, or 
diazomethane
16
. This derivatisation converts hydroxyl and/or acid groups present 
4 
 
in the hydrolysed sapogenin, steroidal (Figure 1.7) and sugar (Figure 1.8) residues 
to non polar analogues which can be analysed using TIC or SIM GC-MS 
techniques. 
Sulfate conjugated analogues are typically harder to cleave via hydrolysis than the 
glycosides. Strongly acidic conditions are required to remove conjugated sulphate 
groups by chemical hydrolysis (solvolysis) such as 4 molar H2SO4 heated to 53°C 
for 1 to 2 hours
17
. The free steroid or triterpene must then be derivatised to a more 
volatile and thermally labile analogue, analogous to the saponins (Figure 1.7). 
Base Hydrolysis 
In the case of conjugated ester analogues (e.g. steroidal fatty acid esters) the initial 
hydrolysis step is usually performed under alkaline conditions and affords the 
parent sterol or sapogenin and fatty acid
18
 (hydrolysis in 90% methanol and 10% 
aqueous K2CO3 solution at 50°C for 18 hours) (Figure 1.4). Thereafter 
derivatisation with reagents such as trimethylsilylchloride or 
trimethylsilylimdazole, acetic anhydride, or diazomethane is required to afford 
GC volatile analogues of the hydrolysed products (Figure 1.7). 
Methylation of Carboxylic Acids 
Carboxylic acid analogues of steroids or triterpenes must be converted to a more 
volatile and thermally labile analogue prior to analysis by GC-MS. A common 
method for increasing the volatility and thermal labiality of carboxylic acid 
analogues is methylation
19
 (Figure 1.9).  
Enzymatic Hydrolysis 
Enzymatic hydrolysis can achieve good efficiency without exposing the 
compound to the elevated temperatures associated with chemical hydrolysis. The 
choice of the enzyme and method is dependent upon the conjugate moiety and the 
steroid structure. Common sources of enzymes used for the cleavage of conjugate 
moieties are bacterial (Escherichia coli) and mollusc (Helix pomatia and Patella 
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vulgata). Bacterial sources of enzymes only contain β-glucoronidase activity 
(Figure 1.5), whilst mollusc sources contain both β-glucoronidase and sulfatase 
(Figure 1.6) activity. The sulfatase activity from the molluscs is weak and highly 
specific to the structure of the conjugated steroidal sulfate
8
. 
Reactions commonly used for removal of conjugated groups from steroidal 
or triterpenoidal compounds to aid analysis via GC-MS; (Figure 1.3-1.6) 
 
Figure 1.3. Acid hydrolysis of a saponin 
HO
OCH3
O
HO
OHCH3
O
HO
[OH]
-
 
Figure 1.4. Alkaline hydrolysis of a fatty acid ester analogue 
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Figure 1.5. Enzymatic hydrolysis of a glycoside 
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Figure 1.6. Enzymatic hydrolysis of a sulphate 
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Reactions commonly used for increasing the volatility and thermal labiality 
of steroids and triterpenes for analysis via GC-MS; (Figure 1.7-1.9) 
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Figure 1.7. Trimethylsilylation of the hydroxyl group of a steroid 
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Figure 1.8. Trimethylsilylation of the hydroxyl groups of a sugar  
 
Figure 1.9. Methylation of an acid group to a COOMe group 
While the fore mentioned procedures can be used to identify and quantify the 
aglycone component of conjugated genins, they do not identify the gross structure 
of the conjugated analogues. In particular, information concerning the point of 
attachment of gylcosyl residues to steroidal or sapogenin skeletons is lost, as is 
information concerning the nature of glycoside linkages (α- or β-) at anomeric 
carbons. The identity of the specific conjugated group attached to a specific 
steroid or triterpene is also lost upon removal of the conjugate group. 
1.1.1.2 GC-MS Ionisation 
GC-MS techniques generally use a ‘hard’ ionisation technique such as electron 
impact ionisation (EI). Hard ionisation techniques cause a larger degree of 
fragmentation than ‘soft’ ionisation techniques, resulting in less chance of seeing 
the molecular ion or pseudo-molecular ion. The application of hard MS ionisation 
techniques such as EI techniques on gas phase analytes tend to afford more 
HO OH
OH
O
O
HO OH
OH
O
OH
Acetylchloride:MeOH 1:20 @ 50°C
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predictable and reproducible MS data than is the case with softer chemical 
ionisation techniques on liquid phase analytes typical of LC-MS
20
. 
Soft ionisation techniques such as atmospheric pressure chemical ionisation 
(APCI) techniques can be coupled to GC-MS instrumentation resulting in reduced 
fragmentation of the analyte
20
. The analyte, however, must still be volatile to 
allow it to be introduced via the GC column. The lack of volatility associated with 
many conjugated analogues of genins means these compounds still require pre-
analysis structural modification before analysis by GC-MS. 
1.1.2 Analysis of Steroids and Triterpenoids using LC-MS 
Since LC-MS separates and detects analytes in the liquid phase it can detect polar 
compounds without prior structural modification, providing the compounds are 
soluble in the liquid phase. Therefore LC-MS, unlike GC-MS, can be performed 
on conjugated gennins without the requirement for acid or base hydrolysis of 
parent glycoside, sulfate, or fatty acid ester analogues
8
. 
 Since the introduction of LC-MS instrumentation there has been a gradual shift to 
measuring some of the compounds more problematic under GC-MS techniques to 
LC-MS techniques. Like GC-MS, LC-MS has some significant limitations. The 
chromatographic resolution than can be achieved using a LC column packed with 
5 µm stationary phase particles is much less than can be achieved using a capillary 
GC column. The reduced chromatographic separation of analyte peaks in LC-MS 
methodologies are frequently compensated for by utilising selective reaction 
monitoring (SRM), where a specific ion from the analyte is collected and 
fragmented to daughter ions that uniquely identify that analyte. 
Another major limitation of LC-MS methodologies are the difficulties associated 
with ionising compounds of neutral or low polarity in liquid matrices. LC-MS 
techniques are more prone to ionisation difficulties than GC-MS, these are in part 
due to the liquid matrices
20
. The factors of significance in the ionisation of 
analytes in LC-MS are discussed below.  
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1.1.2.1 LC-MS Ionisation 
LC-MS typically uses soft ionisation techniques and therefore causes much less 
fragmentation and is more likely to generate the pseudo-molecular ion. A 
significant disadvantage of soft ionisation techniques is that they do not induce 
ionisation of the analyte to the same extent achieved using hard ionisation 
techniques
20
. 
Generation of the pseudo-molecular ion can identify the molecular weight of an 
analyte, and opens up the possibility of progressive MS
2
, MS
3
, MS
n
 fragmentation 
of the pseudo-molecular ion under controlled conditions. The ability of the soft 
ionisation techniques to induce a charge on the analyte is highly dependent upon 
the structure of the analyte
20-22
. Steroidal and triterpenoidal compounds are 
typically thought of as difficult to ionise compounds using soft ionisation 
techniques
22
.  
Two major reasons exist for lack of reliability of soft ionisation techniques; 
(i) Ionisation of the analyte is usually incomplete and many of the analyte 
molecules pass through the ionisation interface unionised.  
(ii) The matrix that the analytes are analysed in changes as the compounds 
in that sample elute through the chromatographic column. 
To minimise the effect matrix exerts upon the ionisation of the target analytes 
ionisation agents are added in to the eluent
20
. Ionisation agents function by 
buffering the eluent solution so the effective ionisation conditions are similar 
throughout the chromatogram, and to aid ionisation which increases the ion 
response seen at the detector. 
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1.2 Analysis of Conjugated Steroidal and Triterpenoidal 
Compounds 
1.2.1 Identification of Saponins and Sapogenins by LC-MS 
Saponins are naturally occurring surface-active glycosides possessing a steroidal 
or triterpenoid alycone component linked to one or more glycoside residue
23
. 
While saponins are predominantly produced by plants they also found in lower 
marine animals and synthesised by some bacteria
24, 23
.  
The identification of parent saponins using LC-MS techniques, as opposed to only 
the hydrolysed algycone using GC-MS techniques, is beneficial in that saponins 
containing the same algycone group may possess differing physiology activities 
and their metabolism (fate) in ovine or other environments often differ. 
Determining the specific pairing of genins and their conjugate glycoside groups 
are indiscernible with GC-MS methodologies as GC-MS is unable to detect the 
parent saponin
15, 25
. 
SRM can be applied to the analysis of both saponins and sapogenins, with good 
specificity based on knowledge of daughter ion fragmentation characteristics of a 
target analyte, however, SRM may not distinguish stereoisomeric forms of a 
particular saponin unless a significant difference in the fragmentation 
characteristics are present. 
GC-MS can generally distinguish stereoisomeric forms of free sapogenins or 
acetylated analogues by comparing fragmentation pattern ion intensities and 
retention time data 
16, 25, 26
. In some circumstances the levels of pairs of 
unresolved or only partially resolved peaks can be determined by comparing the 
ratio of selected pairs of fragment ions determined for the mixed peak, with those 
determined for pure specimens of the two contributing compounds. The same 
principles can be applied to LC-MS to see if similar correlations can be observed. 
This technique is covered in more detail in Section 4.5.1. 
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Various applications requiring the identification and quantification of saponins in 
their conjugated forms are currently of interest at the University of Waikato. The 
application to be investigated in this research involves the need for the 
identification and quantification of saponins implicated as possible causative 
agents in the development of hepatogenous photo-sensitisation diseases of sheep. 
1.2.1.1 Saponins and Sapogenins Implicated in Hepatogenous Photo-
Sensitisation Diseases 
Episarsasapogenin and epismilagenin glucuronides have been implicated as 
possible causative or marker agents in several plant associated photo-sensitisation 
diseases of sheep, cattle and other ruminant animals
12-14, 27
. The current analytical 
methodology utilised in these studies has involved the isolation of extracts 
containing free and conjugated sapogenins (dichloromethane and methanol 
extracts respectively), followed by hydrolysis of the conjugated extracts and GC-
MS analysis of acetylated genins present in these extracts
27, 28
. 
The structures of the saponins present in many of the plants implicated in the 
development of hepatogenous photo-sensitisation are known, as are aspects of the 
ruminal conversions of free genins and subsequent isomerisation to episapogenins 
(3α-OH analogues)15, 28. Little is known about the nature of conjugated genins 
present in post rumen gastrointestinal tract samples other than that the bile crystals 
recovered from animals exhibiting disease symptoms have been found to be 
calcium salts of epismilagenin and/or episarsasapogenin β-D-glucuronides12-14. 
Specifically it is not known if the conjugated saponins present in post-rumen 
samples are unhydrolysed or partly hydrolysed analogues of ingested plant 
saponins or other conjugated analogues (eg sulphates, phosphates).  
It is anticipated that LC-MS
n
 analysis can be used to identify conjugated 
sapogenins present in gastrointestinal tract samples and to determine whether or 
not only epismilagenin or episarsasapogenin conjugates were selectively absorbed 
in the small intestine and transported to the liver where they appeared to be 
precipitated as the calcium salts of epismilagenin and/or episarsasapogenin β-D-
11 
 
glucuronides. By having a more detailed understanding of these processes, 
including the total array of conjugated steroids (saponins) that are present in the 
bile crystals, gastrointestinal tract, and feed stock of animals suffering photo-
sensitisation diseases, it can be anticipated that a better understanding of the 
processes involved in the development of disease symptoms will be derived. 
Based on field observations that within a flock grazing the same pasture not all 
animals appear to be prone to the development of photo-sensitisation symptoms. It 
has been proposed that some animals may be more prone to the development of 
photo-sensitisation symptoms than others, and that this might be a genetically 
influenced characteristic
29
. Currently a Brazilian veterinary group is separating a 
flock of sheep grazing saponin containing plants over a four year trial period into 
susceptible and non-susceptible groups, in the expectation that resistance 
susceptibility night be an inheritable characteristic. Possibly genetic factors may 
influence the nature of conjugates in the rumen and their conversion to conjugate 
analogues including glycosides, sulfates, phosphates or the bile acid type 
analogues of taurine and/or glycine. If so the availability of LC-MS methods to 
probe the nature and distribution of conjugated sapogenins in rumen and GI tact 
samples may assist in the identification of susceptible and resistant animals. 
The selective breeding approach has been successfully applied in the context to 
the identification of sheep that exhibit more or less susceptibility to sporidesmin 
toxicities in New Zealand
30
. Sporidesmin causes a primary photo-sensitisation 
disease in sheep grazing affected pastures. 
1.3 Research Aims and Objectives 
The principle objectives of the investigation reported in this thesis were to 
determine optimal LC-MS conditions for the analysis of saponins and sapogenins 
implicated in photo-sensitisation diseases of livestock, using the University of 
Waikato’s Thermo Finnigan LCQ Advantage LC-MS system. Only limited 
sensitivity (much less than that which was considered acceptable) had been 
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obtained in previous investigations of a variety of free and conjugated steroidal 
and triterpene substrates, including estrogenic sterols
31
.  
In order to address the disappointing sensitivity of the University of Waikato’s 
LC-MS system, and in the absence of a budget to purchase a higher performance 
mass spectrometry system (e.g. an updated Thermo Finnigan LTQ system, or a 
triple quad MS system) it was desirable that a systematic evaluation of instrument 
specific factors which influence the overall sensitivity for detecting free and 
conjugated sapogenins was undertaken. The research was undertaken with a view 
to the identification of conditions which could be applied to the analyses of free 
and conjugated sapogenins recovered from the rumen and GI tract of sheep in a 
breeding trial in Brazil. In order to address quarantine and bio security conditions, 
it is envisaged that when the samples become available (after two to three years of 
selective breeding) biological material (freeze dried rumen, GI tract, etc) will be 
processed and extracted and the resulting non-biological material would be 
forwarded to the collaborating groups with appropriate LC-MS expertise at the 
University of Waikato, or the National Veterinary Institute (Oslo). 
To achieve the objectives required for LC-MS analysis of the sapogenins and their 
conjugated analogues it was determined there was a need to; 
(i) Evaluate the factors that contribute to the ionisation efficiency and 
consequentially the sensitivity of LC-MS analyses of the saponins and 
sapogenins associated with hepatogenous photo-sensitisation diseases.  
(ii) Determine the LC-MS fragmentation characteristics of model saponins 
and sapogenins associated with hepatogenous photo-sensitisation diseases 
with the intention of elucidating an LC-MS method for their identification 
and quantification. A supplementary objective of the sapogenin 
investigations was to determine whether not MS
n
 ion intensities could be 
used to define the C-3, C-5 and/or C-25 chemistry of genins in a manner 
analogous to that previously reported using GC-MS ion ratio data
16, 25, 26
.  
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2 Analysis of Steroids and Triterpenoids via LC-MS 
As discussed in Chapter 1 it was anticipated that a research programme, namely 
that directed towards the characterisation groups of plant saponins and sapogenins 
implicated in the development of hepatogenous photo-sensitisation diseases of 
livestock would benefit from the development on LC-MS methodologies which 
would supplement existing GC-MS methodologies. Prime objectives of the LC-
MS investigations were the identification of conditions which overcome the 
sensitivity limitations encountered in earlier University of Waikato studies on 
steroidal or triterpenoidal compounds. 
 While literature information concerning acquisition conditions utilised in related 
studies by other workers is helpful, it does not of itself serve to define optimal 
conditions on the University of Waikato LC-MS system since it is well known 
that optimum conditions vary for system to system. These factors depend on a 
range of factors including subtle differences in interface design, such as heated 
capillary tube length and diameter, ionisation source layout and geometry, etc. 
2.1 LC-MS Instrumentation 
A simplistic description of a LC-MS system as a series of functional modules 
consists of an, Auto Sampler → Chromatographic Column → Ionisation Source 
→ Mass Separation Device → Detector. 
 
Figure 2.1. Schematic diagram of a LC-MS system 
Autosampler
Eluent
Chromatographic
 Column
Ionisation
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Mass 
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A typical LC-MS system consists of an auto-sampler that injects a liquid sample 
to a chromatographic column where it is eluted isocratically, or gradient-wise, 
with a suitable solvent or solvent mixture. Compounds with differing affinities for 
the column will get eluted off at different retention times. 
 Following separation, the analytes are then transported to the ionisation interface 
in the eluent flow, upon arrival the eluent and analytes are ionised by a complex 
process which involves creating charged droplets followed by removal of the 
solvent matrix from these droplets. This can lead to a variety of ions including 
[M+H]
+
, [M+Na]
+
, [M+NH4]
+
, [M2+H]
+
, and [M2+Na]
+
 ions, depending in part on 
ions intentionally added to eluent buffers (eg H
+
 ions ex formic acid) or present in 
trace levels in the aqueous buffer solutions (eg Na
+
 ions). 
 Once ionised, the mass spectrometer then separates the ions by their mass to 
charge ratio, using either a quadrupole stage or an ion trap cavity from which ions 
are expelled as a function of their mass, before sending them to the detector. Other 
non-destructive detectors (e.g. UV-vis, or refractive index detectors) may be 
connected inline into the eluent stream post chromatographic separation to detect 
analytes prior to the mass spectrometer. 
The University of Waikato LC-MS instrumentation consists of a Thermo Finnigan 
Advantage LCQ instrument, comprising of a Surveyor auto-sampler, Surveyor LC 
pump, Surveyor diode array UV-vis detector, and a Thermo Finnigan Advantage 
LCQ mass spectrometer. The intention of this thesis is to optimise the instrument 
parameters affecting the detection of steroidal and triterpenoidal compounds and 
their conjugated analogues, allowing a wider variety of compounds to be 
measured by LC-MS at the University of Waikato. 
  
15 
 
2.1.1 Liquid Chromatography 
The liquid chromatography system separates compounds in the liquid phase based 
on their relative affinities for the surface of the stationary phase of the column and 
eluent. Compounds that have a stronger affinity for the stationary phase will take 
longer to elute through the column than those with a weak affinity
32
. By using a 
column with an appropriately coated stationary phase and adjusting the eluent 
composition it is possible to achieve adequate separation of chromatographic 
peaks for most compounds using liquid chromatography, provided they are 
soluble in the mobile phase. Resolution using liquid chromatography is not as 
pronounced as can be achieved using gas chromatography, and peak overlap is 
often observed. To overcome the limitations of liquid chromatographic separation 
the mass spectrometer can be used to select parent → daughter ion combinations 
that are specific to that particular analyte (SRM). 
Liquid chromatographic columns are available in differing dimensions and 
stationary phases. A liquid chromatographic column should be selected that 
enables adequate separation of analytes, is compatible with the liquid 
chromatographic systems flow requirements, and is inert to reaction with the 
eluent, analytes, or matrix of the samples. 
2.1.2 Mass Spectrometric Detection 
Mass spectrometry systems detect analytes by placing a charge on the analyte, 
followed by separation based upon the mass to charge ratio of the analyte, the 
charged analyte of specific mass to charge then reaches the detector where it is 
converted into a signal which is deciphered by a computer. Literature suggests 
that placing a charge on the analyte (ionisation) is usually the limiting factor in 
LC-MS detection of steroidal and triterpenoidal compounds
21, 22
. Further 
discussions into the factors affecting ionisation in LC-MS applications can be 
found from Sections 2.1.3, to 2.1.4. 
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The University of Waikato Thermo Finnigan Advantage LCQ instrument is an ion 
trap mass spectrometer. As eluded to in Sections 1.1.2 and 2.1.1, an ion trap mass 
spectrometer enables multiple fragmentations to be carried out in a sequence, 
allowing development and implementation of SRM methodologies. SRM 
methodologies require that the fragmentation patterns of specific analytes be 
investigated so a diagnostic parent to daughter ion fragmentation specific for the 
analyte can be selected. Upon generation of diagnostic fragmentation patterns 
specific to the analyte a SRM method that monitors that specific fragmentation 
during a chromatographic run can be developed. High sensitivity analysis utilising 
triple quadrupole MS technology requires knowledge of compound specific SRM 
transitions. 
2.1.3 Ionisation of Steroidal and Triterpenoidal Compounds and 
Their Conjugated Analogues 
It is well known that steroidal and/or triterpenoidal compounds can be hard to 
ionise in a mass spectrometer, and that the conditions required to achieve efficient 
ionisation can vary from molecule to molecule depending on the parent ring 
system, the substituent groups present in a molecule and the ionisation source 
used
22
. 
 Ionisation of the analyte is considered to be the limiting step for the analysis of 
steroids by LC-MS
22
. By investigating the ionisation characteristics of a selection 
of genins that may be of interest to the University of Waikato Chemistry 
Department, it was anticipated that parameters which influenced the effective 
analysis of these steroids could identified and their contributions maximised. 
 The University of Waikato’s LCQ Advantage instrument has two ionisation 
interfaces: electro-spray ionisation (ESI) and atmospheric pressure chemical 
ionisation (APCI). Variables that can be manipulated include the type of inlet, 
eluent, ionisation agent composition and concentrations can be manipulated to 
maximise the ion response seen for a particular analyte.  
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ESI and APCI ionisation sources have benefits and disadvantages with respect to 
each other. These benefits and disadvantages are often analyte, and sample matrix 
specific, so the most suitable interface for one compound may not be the most 
suitable for another compound. A general observation made by Gomes
8
 on the 
topic of steroid analysis is that ‘Though greater sensitivity is achievable by ESI, 
matrix effects are less for APCI’. 
2.1.3.1 Electro-Spray Ionisation ESI 
ESI is the most widely used interface used in LC-MS applications
20, and is a ‘soft’ 
ionisation technique. ESI operates by exposing the analytes in the solvated matrix 
to a charge while it sprayed through a small capillary which induces ionisation of 
easily ionisable components of the eluent mixture (eg ionisation agents such as 
formic acid). Solvent is progressively removed via evaporation in the ESI and 
heated capillary interfaces resulting in charged analyte molecules. During these 
complex processes analyte species form ions such as [M+H]
+
, [M+Na]
+
, and 
[M2+H]
+
 which are detected at the mass spectrometer
20, 32, 33
. The ESI inlet allows 
the adjustment of capillary temperature, capillary and source voltages, along with 
physical alignment of the spray nozzle. 
 ESI is reported to show a correlation between ion intensity detected at the mass 
spectrometer and the concentration of the analyte in the eluent
20, 32, 33
. The 
correlation shows the larger the concentration of analyte in the eluent the larger 
the detected ion intensity. By reducing the flow of eluent through an ESI interface 
it may be possible to enhance the detection of the analyte. ESI should obtain 
better ionisation efficiencies at lower flow rates through the LC column. The 
optimal flow rate will be a compromise between, retention time, peak broadening, 
and analyte concentration in the eluent. 
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2.1.3.2 Atmospheric Pressure Chemical Ionisation (APCI) 
APCI is a slightly harder ionisation technique than ESI, but still considered soft. 
APCI operates by exposing analytes in the solvated matrix to an elevated 
temperature in the source capillary to convert the analytes and solute to the 
gaseous phase before spraying the gas towards a charged ‘probe’ which ionises 
the analyte via complex mechanisms. The partially solvated analyte ions are then 
exposed to conditions to aid removal of the solvate and unionised molecules from 
the charged analytes, before guiding the de-solvated charged analytes into the 
mass spectrometer almost analogous to ESI. 
 APCI generally induces a larger degree of thermal decomposition of the analytes 
than the softer ESI. This is at least partially due to the increased exposure of the 
analyte to heat in the APCI source relative to the ESI source. APCI is particularly 
suited to analysis of volatile, thermally stable analytes and is ineffective at 
ionising compounds with low vapour pressures and are thermally labile such as 
sugars
20
. 
APCI is reported to show an ion intensity detected at the mass spectrometer that 
correlates with the quantity of the analyte in the eluent
20
, thus the observed 
intensity should be proportional to the quantity of analyte in the detector. LC-MS 
analysis using an APCI interface should (reputably) exhibit a response that is 
relatively independent of flow rate. 
2.1.3.3 Eluent 
An ideal eluent would be capable of dissolving the analyte, cause analytes to elute 
with adequate peak separation, be inert to reacting with the analyte during the 
liquid chromatography separation, provide adequate ionisation of the analyte in 
the ionisation interface and be volatile. No one solvent can perform all these tasks, 
so a graidient of multiple solvents and ionisation agents are combined to 
approximate an ideal eluent. 
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 In LC-MS most experiments are carried out on a reverse phase column, using an 
eluent gradient of water/acetonitrile (ACN) or water/methanol. The eluent 
gradient generally starts with a polar water biased solvent mixture and gradually 
becoming less polar. The polar compounds should elute of first in the water biased 
portion of the gradient followed progressively by the less polar compounds. Often 
methodologies employ an eluent gradient starting with polar solvents so that many 
interfering (ion suppressing) compounds can be eluted off first preventing them 
affecting the analysis for the target analyte. 
 Some concern exists that methanol may not be inert toward some of the analytes 
under acidic conditions, as would be present if an acidic ionisation agent was used 
with methanol as the organic component of the eluent
34
. The eluent cannot be too 
non-polar as some polarity is required for effective ionisation and the eluent must 
be miscible with water if a gradient is applied utilising water. 
In LC-MS ionisation can be heavily influenced by the eluent composition. It has 
been reported that many compounds ionise more efficiently in the non-polar 
region of the eluent composition using ESI. Protriptyline
35
 and cocaine
20
 
ionisation in LC-ESI-MS being specific examples where ionisation was much 
more efficient at higher organic (ACN) composition. 
 The effect eluent composition exerts upon ionisation will be investigated for a 
variety of model compounds, using both ESI and APCI interfaces. It is feasible 
that the optimal eluent composition may be different for the two ionisation 
interfaces as the mechanism of ionisation for each ionisation interface differs. The 
ability of the eluent to promote efficient ionisation may be of significance when 
an appropriate chromatographic column is selected for analysis of specific 
compounds. The investigation was restricted to ACN as the preferred organic 
eluent for its relative inertness and the favourable ionisation properties reported in 
literature
20, 22, 34
. 
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2.1.3.4 Ionisation Agents 
Ionisation agents are added to the eluent to act as an ionisation aid by increasing 
the efficiency of ionisation of the analyte, and act as an ionisation buffer by 
providing a matrix that is consistent between samples causing even ionisation of 
the analyte. The ionisation aid can have a large effect upon the efficiency of 
ionisation in the ionisation interface. Due to the large possibility of ionisation 
agents the number to be investigated will be limited to an acidic ionisation agent - 
formic acid, a weakly acidic ionisation agent - ammonium formate, and an 
alkaline ionisation agent - ammonium carbonate. A secondary benefit of many 
ionisation agents is the improvement many can make to the LC resolution and 
repeatablitiy. 
 In the positive ion spectrum, the acidic ionisation agent is expected to produce 
[M+H]
+
 pseudo-molecular ions, the ammonium formate ionisation agent is 
expected to produce [M+NH4]
+
 pseudo-molecular ions and/or [M+H]
+
 pseudo-
molecular ions, and the ammonium carbonate ionisation agent is expected to 
produce [M+NH4]
+
. Cluster ions such as [M2H]
+
 and dehydration products such as 
[M-H2O+H]
+
 may also be formed. 
In the negative ion spectrum, [M-H]
-
 are commonly formed as pseudo-molecular 
ions. Cluster ions and dehydration products may also be formed in the negative 
ion spectrum. Under some circumstance [M+X]
-
 ions may also be formed where 
X
-
 ions such as Cl
-
 or COOH
-
 are present in a buffer. Alkaline ionisation agents 
are expected to be favourable to the generation of negative [M-H]
-
 and [M]
-
 
pseudo-molecular ions.  
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2.1.3.5 Signal Suppression 
Signal suppression the term applied to phenomena which cause attenuation of the 
ion current produced by a given amount of analyte in the sample. Such 
phenomena that cause attenuation of the ion current can result from both chemical 
and physical factors
20
. Signal suppression is a serious consideration for all LC-MS 
methodologies, and if not taken into account can result in detector response values 
that invalidate the quantification
36, 37
. 
Minimising signal suppression in the eluent system can be achieved by selecting 
appropriate eluent and ionisation agent combinations that promote ionisation of 
the analyte and buffer factors that affect ionisation such as solution pH and 
electrolyte concentration. Such appropriate combinations of eluent and ionisation 
agents are often specific to a class of compound, or even an individual analyte
22
. 
Many of the buffers used to obtain good resolution in high performance liquid 
chromatography (HPLC) can cause attenuation of the ion current for many 
compounds in LC-MS
20
. 
 Buffers that result in generation of a mixture of ions (for example [M+H]
+
 and 
[M+NH4]
+
) can reduce the effective intensity of the analyte ions and therefore 
reducing detection limits. Signal suppression can also be caused by the presence 
of signal suppressing compounds in sample matrices and cause signal suppression 
that fluctuates throughout a chromatographic run as the offending signal 
suppressing compounds elute through the ionisation interface
38
. Biological fluids 
such as urine
39
 and plasma
40
 can exhibit large effects upon the ion signal observed 
for an analyte. Several methods (processes) have been developed for dealing with 
the variable signal suppression that occurs throughout a chromatographic run due 
to interfering compounds in the matrix
41
.  
Internal standards are routinely used as a means of correcting for the effect of 
signal suppression. An internal standard of known concentration is added to the 
sample and standard matrices prior to analysis. By comparing the signal observed 
for the internal standards of each sample to those of the standards the effect signal 
suppression exerts upon every sample can be determined and compensated for. 
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This method is highly dependent on having matched the internal standards with 
the analytes for chromatographic and ionisation characteristics. Ideal internal 
standards possess the same chromatographic and ionisation characteristics but 
have differentiable fragmentation characteristics. For this reason stable isotope 
analogues of the analyte are often used as internal standards such as poly 
deuterated analogues. The need for matching of chromatographic characteristics 
can be overcome by post column infusing a suitable stable isotope analogue into 
the eluent allowing quantification of the target analytes at any retention time. 
Another method involves manipulating the chromatographic conditions so the 
analyte elutes at a portion of the chromatogram where the signal suppression is 
weak. To achieve this experiments are carried out where the analyte/s are direct 
infused into the eluent steam as a blank sample matrix is injected onto the column. 
The signal for the direct infused analyte/s will reduce in the portions of the 
chromatogram where signal suppressing compounds elute
37
. The elution 
conditions are then manipulated so the analyte/s are not eluted during the same 
period as the offending signal suppressing compounds. 
Alternatively the standard addition method can be employed. The standard 
addition method involves running each sample multiple times with known 
quantities of the analyte added. By subtracting the response of the sample with no 
standard added from the samples with standards added a calibration response 
curve can be generated which compensates for the matrix effects of that sample. 
The response of the sample with no sample added can then be quantified from the 
calibration response curve that was created for that sample. Standard addition 
methods are time consuming and laborious, therefore are not commonly applied in 
routine analysis. However, standard addition is a useful tool in method 
development for the quantifying the effect the matrix exerts (signal suppression). 
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2.1.4 Ionisation via Chemical Derivatisation 
If adequate ionisation of the analytes cannot be achieved via the manipulation of 
ionisation parameters and eluent conditions it may be necessary to perform 
chemical derivatisation to convert the analyte to a form which is ionised prior to 
mass spectrometric separation
42
. Chemical derivatisation process can be carried 
out on samples prior to the analytes being analysed, or the chemical derivatisation 
process can be carried out in the eluent flow after separation by liquid 
chromatography and before the ionisation interface. Both methods have their 
benefits and limitations. 
 For either method to be suitable for the analysis of conjugated steroids or 
conjugated triterpenes, hydrolysis of the conjugated moiety must not occur during 
the derivatisation process. Some structural information will be lost during the 
derivatisation process, but critical information including the identity and point of 
attachment of the conjugate entity should be maintained, provided an appropriate 
derivatisation process is selected. Improving ionisation of analytes via chemical 
derivatisation can be used to produce either positive or negative ions, by careful 
selection of an appropriate derivatisation agent
42
. 
2.1.4.1 Pre-Analysis Chemical Derivatisation 
Pre-analysis chemical derivatisation of analytes can improve the detection of 
problematic compounds significantly. For pre analysis chemical derivatisation to 
be suitable for liquid chromatography the derivatisation process must result in a 
compound that is able to be eluted off the chromatographic column. The 
derivatisation process consists of one or more easily ionised functional groups 
being attached to the target analyte. The easily ionised functional groups get 
ionised as the derivatised analyte passes through the ionisation interface. 
 Ideally the derivatised analyte will be a neutral compound that accepts a single 
charge over the molecule upon ionisation in the ionisation interface. Many 
derivatised products carry a permanent charge which causes the elution properties 
24 
 
to be vastly different to un-derivatised compounds. The different elution 
properties associated with permanently charged derivatives can be used to 
separate the analytes from possible matrix effects and interferences.  
Pre-analysis chemically derivatised analytes elute through the liquid 
chromatographic column at retention times that are as a result of the derivitised 
analyte, so comparisons with liquid chromatographic data for the parent 
compound are not possible. Pre-analysis chemical derivatives that are suitable for 
the type of compounds investigated would selectively attach an easily ionised 
functional group or permanently ionised functional group to hydroxyl or ketone 
functionalities of the analyte. 
 Potentially suitable pre-analysis chemical derivatisation reagents include; 
ferrocene carbamate derivatisation of alcohols
42, 43
, ferrocene boronate 
derivatisation of diols
42, 44, Girard’s reagent P derivatisation of ketones , Girard’s 
reagent T derivatisation of ketones, dansyl chloride derivatisation of hydroxyls 
attached to an aromatic ring, 1,2-dimethylimidazole-4-sulfonyl chloride 
derivatisation of hydroxyls attached to an aromatic ring (phenolic group), 
pyridine-3-sulfonyl chloride derivatisation of hydroxyls attached to an aromatic 
ring, and 4-(1H-pyrazol-1-yl) benzenesulfonyl chloride derivatisation of 
hydroxyls attached to an aromatic ring, mono-(dimethylaminoethyl) succinyl ester 
derivatisation of alcohols
42
. The ferrocene based derivatisation products rely upon 
a platinum capillary for effective ionisation of the derivitised analyte
43
. As the 
University of Waikato does not have a platinum capillary at its deposal, ferrocene 
based derivatisation is currently unsuitable. 
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2.1.4.2 Post Column Chemical Derivatisation 
Post column chemical derivatisation of analytes can improve the detection of 
problematic compounds significantly. For post column chemical derivatisation to 
be suitable the analyte is eluted through the LC column as the parent compound 
before a chemical reagent is added to the eluent flow causing a reaction between 
the chemical reagent and the analyte. Ideally the derivatised product of the analyte 
will either be an ion that holds a singular charge, or a neutral compound that is 
easily ionised to a singularly charged ion in the ionisation interface. A benefit of 
post column derivatisation is the chromatographic data is that of the parent 
compound, causing chromatographic data collected under identical conditions 
where no derivatisation is present to be comparable. Post column chemical 
derivatives that are suitable for the type of compounds investigated would 
selectively and quickly attach an easily ionised functional group or permanently 
ionised functional group to hydroxyl or ketone functionalities of the analyte in the 
eluent prior to the ionisation source. A potentially suitable post column chemical 
derivatisation reagent includes fresh alkaline methanolic ammonia solution as 
used for the detection of oestrogenic sterols and their conjugates
45
. 
 
Figure 2.2. LC-MS system with post column infusion 
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2.2 Target Compounds 
Model compounds investigated were chosen for a combination of their structural 
characteristics, and applications of relevance to curent or pending University of 
Waikato research interests. The model compounds chosen for investigation were 
saponins and sapogenins associated with hepatogenous photo-sensitisation 
diseases of livestock. Model compounds were chosen based upon their 
documented involvement in hepatogenous photo-sensitisation disease of 
livestock
28
, and availability of the compounds. The relevance of developing 
methodology that can benefit the detection within the category is discussed in 
more detail in the following. 
Saponins and sapogenins implicated in hepatogenous photo-sensitisation diseases 
of sheep and goats have been traditionally analysed by GC-MS methods
16
. It has 
been postulated that selected steroidal saponin glycosides are at least partially 
responsible for the bile crystals found in sheep suffering from photo-sensitisation 
diseases (aveld) associated with grazing N. ossifragum
15
. As LC-MS has 
significant advantages for the detection of saponins relative to GC-MS it has been 
hypothesised that detection by LC-MS could be a viable alternative method for 
analysis of the saponins implicated as possible causative agents for heptageneous 
photo-sensitisation diseases of sheep such as aveld. During the course of the topic 
an attempt will be made to develop parameters that aid the analysis of selected 
compounds implicated in the hepatogenous photo-sensitisation diseases of sheep 
and goats by LC-MS methodology.  
Compounds of interest to the investigation of saponins and sapogenins implicated 
in hepatogenous photo-sensitisation diseases of sheep and goats include; 
 Sarsasapogenin, a sapogenin implicated in the hepatogenous photo-
sensitisation diseases in sheep
13, 14
. The IUPAC name for sarsasapogenin is 
(25S) 5β-spirostan-3β-ol. Molecular formula, C27H44O3. Molecular mass, 
416.64 amu 
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Figure 2.3. Structure of sarsasapogenin 
A selection of deuterated analogues of sarsasapogenin and episarsasapogenin were 
made available for the investigation. 2,2,4,4-
2
H4-episarsasapogenin/2,2,4,4-
2
H4-
sarsasapogenin (4:1) and 20,23,23-
2
H3-sarsasapogenin was synthesised during 
previous research into the implication of saponins as causative agents in the 
hepatogenous photo-sensitisation diseases of sheep
46
. The purity and site of 
dueteration of 2,2,4,4-
2
H4-episarsasapogenin/2,2,4,4-
2
H4-sarsasapogenin and 
20,23,23-
2
H3-sarsasapogenin samples were established by NMR and GC-MS 
analysis (Sections 4.24.3). 
 Episarsasapogenin, the C-3 isomer of sarsasapogenin. Episarsasapogenin 
conjugates are formed in-vitro by isomerisation of sarsasapogenin in the 
gastro-intestinal tract of sheep
28
. The IUPAC name for episarsasapogenin 
is (25S)-5β-spirostan-3α-ol. Molecular formula, C27H44O3. Molecular 
mass, 416.64 amu 
O
O
OH
H
 
Figure 2.4. Structure of episarsasapogenin 
 Smilagenin, a lithogenic sapogenin implicated in the photo-sensitisation 
diseases in sheep and goats
13, 14, 16, 47
. The 25R isomer of sarsasapogenin 
The IUPAC name for smilagenin is (25R)-5β-spirostan-3β-ol. Molecular 
formula, C27H44O3. Molecular mass, 416.64 amu 
O
O
HO
H
 
Figure 2.5. Structure of smilagenin 
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 Diosgen, C5(6) alkene analogue of sarsasapogenin. A lithogenic 
sapogenin implicated in the photo-sensitisation diseases in sheep and 
goats
16
. The IUPAC name for diosgenin is (25R)-5β-spirost-5-en-3β-ol. 
Molecular formula, C27H42O3. Molecular mass, 414.63 amu 
O
O
HO  
Figure 2.6. Structure of diosgenin 
 Tigogenin, the C-5 (α-H) isomer of sarsasapogenin. A non-lithogenic 
sapognin that is not implicated in photo-sensitisation diseases of 
livestock
16, 47
. The IUPAC name for tigogenin is (25R)-5α-spirostan-3β-
ol. Molecular formula, C27H44O3. Molecular mass, 416.64 amu 
O
O
H
HO
 
Figure 2.7. Structure of tigogenin 
 Asparagoside A (Sarsasapogenin-β-D-glucoside), a saponin containing an 
aglycone implicated in the photo-sensitisation diseases in sheep and 
goats
13, 14
.The IUPAC name for asparagoside A is (25S)-5β-spirostan-3β-
O-β-D-glucoside. Molecular formula, C33H54O8. Molecular mass, 578.77 
amu. The chemical structure of asparagoside A is given in Figure 1.2 
 Sarsasapogenin-β-D-galactoside, a saponin containing an aglycone 
implicated in the photo-sensitisation diseases in sheep and goats
13, 14
. The 
IUPAC name for sasasapogenin galactoside is (25S)-5β-spirostan-3β-O-β-
D-galactoside. Molecular formula, C33H54O8. Molecular mass, 578.77 amu 
O
O
O
H
O
HO
HO
HO
HO  
Figure 2.8. Structure of sarsasapogenin-β-D-galactoside.
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3 Optimising Ionisation of Saponins and Sapogenins 
3.1 Saponins and Sapogenins Selected for Optimisation of 
Ionisation Parameters 
Two sapogenins and a saponin were selected as model compounds for the 
optimisation of LC-MS responses were compounds implicated in, or isomers of 
compounds implicated in heptageneous photo-sensitisation diseases such as 
Alveld and Geeldikkop
13
. 
The selected compounds were: 
(i) sarsasapogenin and diosgenin - as model sapogenins. 
(ii)  sarsasapogenin-β-D-glucoside - as a model saponin. 
These compounds were selected for the availability of sample and their close 
structural similarity (or identity) with compounds implicated in the development 
of photo-sensitisation diseases of sheep. 
3.1.1 Optimising Ionisation of the Model Compounds 
Two ionisation sources were used in the investigation into optimising ionisation 
of sarsasapogenin, diosgenin, and sarsasapogenin-β-D-glucoside. Both ionisation 
sources have benefits and disadvantages with respect to each other. Idealised 
(clean) matrices were used in the optimisation studies reported below. When 
ovine rumen and GI tract samples become available further optimisation studies 
will need to be performed in order to determine the extent to which actual sample 
matrices influence the respective detector responses since it is well known that 
sample matrices often suppress ionisation of real samples, relative to a clean 
standard matrix
48
. 
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3.2 Electro-Spray Ionisation Source (ESI) 
The application of genin analysis using the ESI inlet as the ionisation source was 
investigated by manipulating parameters affecting ionisation to maximise the ion 
responses of the model compounds. The parameters investigated include; 
alignment of the spray nozzle, cone voltages, ionisation agents, composition of the 
eluent, capillary temperature and eluent flow rate. 
Initial investigations were performed in positive and negative ion modes by direct 
infusing the model compounds into the eluent flow (200 µLmin
-1
 1:1 ACN:H2O, 
capillary temperature 250°C, and 0.01% acetic acid buffer). During these 
investigations, sarsasapogenin gave disappointingly weak ion responses in the 
mass spectrometer. It was concluded poor ionisation was the most probable cause 
of the weak response. 
The three model compounds formed identifiable ions in the positive ion mode, but 
in negative ion mode little if any compound related ion responses were observed. 
Due to the relative ease in which positive ions were generated, the investigation 
into the optimisation of ESI parameters centres on the generation of positive ions, 
in particular pseudo-molecular ions. 
3.2.1 Alignment of the Spray Nozzle in the ESI Source 
The alignment of the ionisation source spray jet was varied while sarsasapogenin 
was infused into the eluent flow via a syringe pump. The alignment of the spray 
jet was found to only exhibit a small effect upon the observed signal in the mass 
spectrometer and not be the cause of the low sensitivity observed. Since alignment 
of the spray nozzle was found not to be the source of the poor ionisation for 
sarsasapogenin the appropriate alignment position utilised for sarsasapogenin was 
used for all other compounds. 
31 
 
3.2.2 Voltage Settings (ESI) 
The voltage settings of the ESI and mass spectrometer were optimised via the 
Auto tune function of the Thermo Finnigan software ‘LCQ Tune’. Typically, a 
0.01 molL
-1
 solution of a model compound was direct infused into the eluent 
stream prior to the ESI inlet. The pseudo-molecular [M+H]
+
 ions of the model 
compounds, sarsasapogenin (m/z 417), for diosgenin (m/z 415), and for 
sarsasapogenin-β-D-glucoside (m/z 579) were utilised when optimising the 
parameters. 
3.2.3 Ionisation Agents (ESI) 
The effect ionisation agents exert upon ionisation of the model compounds were 
investigated by direct infusing 0.001 molL
-1
 of the model compounds into the 
eluent stream just prior to the ESI source and measuring the intensity of the model 
compounds specific ions in the spectra. By recording the ion intensities of the 
spectra during a period the ionisation agent composition had stabilised the effect 
the ionisation agent exerts upon the detected ion intensity can be measured.  
Three ionisation agents were investigated on the model compounds; formic acid, 
ammonium formate, and ammonium carbonate. Experimental parameters for the 
collection of the data were 200 µLmin
-1
 1:1 ACN: H2O eluent, capillary 
temperature 300°C, 0.01% (v/v) formic acid, 0.01 molL
-1
 ammonium formate, and 
0.01 molL
-1
 ammonium bicarbonate in the ACN. This produced eluent 
compositions of 0.005% (v/v) formic acid, 0.005 molL
-1
 ammonium formate, and 
0.005 molL
-1
 ammonium bicarbonate respectively. 
It was found that formic acid achieved the best ionisation of the three agents 
tested for positive ion spectra of all three model compounds (Figure 3.1, 3.3 and 
3.5). As the most promising ionisation agent, the effect concentration of formic 
acid in the eluent was investigated on the model compounds (Figure 3.2, 3.4 and 
3.6). Experimental conditions were as described previously (above) with the 
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exception that the eluent consisted of 1:1 ACN:H2O with 0.1%, 0.05%, 0.024%, 
0.005%, and 0% formic acid in the eluent. The ESI interface settings were 
optimised using sarsasapogenin-β-D-glucoside as described in Section 3.2.2.  
The presence of formic acid in the eluent was found to be beneficial to the 
ionisation of the model compounds, with an observed general trend showing a 
reduction of ion intensity when no formic acid was present in the eluent for all 
three model compounds (Figure 3.2, 3.4 and 3.6). 
3.2.3.1 Sarsasapogenin 
Sarsasapogenin showed greater ionisation in the presence of formic acid than was 
the case for other ionisation agents investigated (Figure 3.1). 
 
Figure 3.1. ESI responses for sarsasapogenin in three ionisation agents 
The concentration of formic acid in the eluent was found to exhibit a small effect 
upon the ionisation of sarsasapogenin as can be seen in Figure 3.2. The intensity 
of the ion response with no formic acid present was approximately two thirds of 
that observed for 0.05% formic acid. 
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Figure 3.2. Effect of formic acid concentration upon the ESI response of 
sarsasapogenin  
3.2.3.2 Diosgenin 
Like sarsasapogenin, diosgenin showed preferential ionisation with formic acid as 
the ionisation agent (Figure 3.3). 
 
Figure 3.3. ESI responses for diosgenin in three ionisation agents 
The concentration of formic acid in the eluent was found to exhibit a small effect 
upon the ionisation of diosgenin (Figure 3.4). The intensity of the ion response 
with no formic acid present was approximately half of that observed for 0.05 and 
0.1% formic acid. 
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Figure 3.4. Effect of formic acid concentration upon the ESI response of 
diosgenin 
3.2.3.3 Sarsasapogenin-β-D-glucoside 
Like sarsasapogenin and diosgenin, sarsasapogenin-β-D-glucoside showed 
preferential ionisation with formic acid as the ionisation agent. A satisfactory 
response was also observed using ammonium formate (Figure 3.5). 
 
Figure 3.5. ESI responses for sarsasapogenin-β-D-glucoside in three 
ionisation agents 
The concentration of formic acid in the eluent was found to exhibit a small effect 
upon the ionisation of sarsasapogenin-β-D-glucoside (Figure 3.6). The intensity of 
the ion response with no formic acid present was approximately half of that 
observed for 0.05 and 0.1% formic acid. 
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Figure 3.6. Effect of formic acid concentration upon the ESI reponse of 
sarsasapogenin-β-D-glucoside 
3.2.4 Eluent Composition (ESI) 
Direct infusion experiments. The composition of the eluent was varied from 
0:100 (ACN-H2O) to 100:0 (ACN-H2O) as the model compounds were directly 
infused into the eluent stream just prior to the ESI source. Ion intensities were 
recorded during a period the eluent composition had stabilised A significant 
advantage of the direct infusion experiments was that the eluent composition was 
not limited by the composition of the solvent mixture required to elute a model 
compound through an LC column. Direct infusion enabled the influence solvent 
mixture comprised of 0-100% ACN to be determined (Sections 3.2.4.1-3.2.4.3). 
Chromatographic experiments. Chromatographic experiments were undertaken 
to confirm or disprove the data trends observed in the direct infusion experiments. 
Chromatographic data was collected by eluting model compounds through a 
Phenomenex Prodigy 150 mm x 2.00 mm 5 µm C-18 LC column at various 
isocratic eluent compositions (ACN-H2O, + 0.01% formic acid) and quantifying 
the peak areas (ion responses) observed for the corresponding pseudo-molecular 
ion. It was anticipated that chromatographic data should model the trends seen in 
the direct infusion experiments. Investigations were constrained to the range of 
solvent mixtures that could be employed to elute targets compounds for the C-18 
LC column in a reasonable time.  
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3.2.4.1 Sarsasapognin 
Direct infusion, ESI inlet; Sarsasapogenin was infused via a syringe pump just 
prior to the ionisation inlet into an ACN-H2O eluent mixtures containing 0.01% 
formic acid. In all cases the eluent flow rate of 200 µLmin
-1
. It was that the 
composition of the eluent had a large effect upon the intensity of the fragment 
ions observed (Figure 3.7). The maximum intensity of [M+H]
+
 m/z 417 ion 
occurred at an eluent composition between 50 and 60% ACN.  
 
Figure 3.7. Effect of eluent composition upon the ESI response of 
sarsasapogenin 
Using a C-18 LC column sarsasapogenin can be eluted using 80-100% ACN-H20 
mixtures either isocratically or as part of gradient elution programme before the 
retention time and flow rates become impractical. For this reason sarsasapogenin 
elutes from the C-18 column where the ionisation is unfavourable in the ACN-
H2O eluent composition. The ionisation current observed for m/z 417 [M+H]
+
 of 
sarsasapogenin is 220 times higher in the presence of 1:1 ACN-H2O than is the 
case for 100% ACN. 
Chromatographic data, ESI inlet; Chromatographic experiments performed by 
injecting 10
-9
 mol of sarsasapogenin onto the C-18 column and eluting it using 
isocratic compositions of 100:0, 90:10, and 80:20 (ACN-H2O, + 0.01% formic 
acid) verified the downward trend seen in the direct infusion experiments as the 
percent ACN was increased. Peak areas for TIC, [M+H]
+
, and MS
2
 on [M+H]
+
 
ions are shown in Figure 3.8. Chromatographic experiments were performed using 
a capillary temperature of 300°C and a flow rate 400 µLmin
-1
. The extent to 
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which the ionisation decreased as the percent ACN increased was were slightly 
lower than that observed in direct infusion. This reduction may, at least in part, be 
attributed to the higher flow rates used in the chromatographic experiment relative 
to those used in the direct infusion experiment. 
 
Figure 3.8. Effect of eluent composition upon the ESI response of 
sarsasapogenin 
Several methods of manipulating the eluent composition exist so sarsasapogenin 
elutes from an LC column at a composition that is beneficial to its ionisation. 
Options include changing the LC column to one that allows sarsasapogenin to 
elute using a solvent mixture containing higher percent of water. For example a C-
8, rather than C-18 column could be used. It is appears from the data represented 
in Figures 3.7 and 3.8 that it would be beneficial to add water post column to the 
eluent flow. The increase in ion intensity seen for the eluent composition would 
be much greater than the decrease in intensity due to dilution. 
Assuming the ionisation is approximately proportional to the concentration of 
analyte for the ESI interface
20
 the expected ion intensity can be calculated. The 
direct infusion data presented in (Figure 3.7) was utilised to estimate ion current 
intensities that would be observed with appropriate dilution from post column 
addition of water using 100% ACN as the LC eluent (Figure 3.9). 
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Figure 3.9. The estimated effect post column infusion of water would have 
upon the ESI reponse of sarsasapogenin 
Unexpectedly however an experiment using 100% ACN (+0.01% formic acid) as 
the LC column eluent and infusing water (+0.01% formic acid) post column into 
the eluent flow did not result in a significant increase in intensity relative to the 
use of 100% ACN as eluent. It is hypothesised that the non-observation of an 
increase of ionisation intensity during the post column infusion experiments may 
be due to the eluent being heterogenous as it enters the ESI interface due to the 
inadequate mixing of the infused water with the LC eluent If so, the 
heterogeneous eluent formed as a result of inadequate mixing of the eluents may 
be able to be minimised by infusing the water further ‘upstream’ in the eluent 
flow and (or) extending the length of the capillary tube between the point of 
infusion and the ESI inlet. 
3.2.4.2 Diosgenin 
Eluent composition was varied as 0.01 molL
-1
 diosgenin was directly infused via a 
syringe pump immediately prior to the ESI source into ACN-H2O eluent mixtures 
contained 0.01% formic acid (flow rate 200 µLmin
-1
). Ion responses were 
determined when the eluent had stabilised. It was found that the composition of 
the eluent had a large effect upon the intensity of [M-H]
+
 and fragment ions that 
were observed (Figure 3.10). 
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Figure 3.10. Effect of eluent composition upon the ESI response of diosgenin 
The maximum intensity of [M+H]
+
 m/z 415 ion response occurred at an eluent 
composition of ca 60% ACN. Diosgenin can be eluted in the 100% to 70% ACN 
portion of the elution gradient using the available C-18 column before the 
retention time and flow rates become impractical. Thus when using a C-18 
column diosgenin elutes where the eluent composition greatly suppresses 
ionisation (Figure 3.10). The intensity observed for m/z 415 [M+H]
+ 
ion is 105 
times higher at 60% ACN than it is using 100% ACN.  
Direct infusion data and chromatographic runs at isocratic eluent compositions of 
100%, 90%, 80% and 70% ACN showed at similar downward trend in ionisation 
responses as thepercentof ACN increased from 70 to 100% (Figure 3.11). 
 
Figure 3.11. Effect of eluent composition upon the ESI peak area diosgenin 
Post column infusion of water into the eluent as desricribed above for 
sarsasapogenin was investigated. The theoretical increase in sensitivity expected 
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for this experiment is depicted in Figure 3.12. As was the case for sarsasapogenin, 
no significant increase in ionisation was observed for diosgenin when water was 
infused into the eluent stream post column. 
 
Figure 3.12. The estimated effect post column infusion of water would have 
upon ESI reponses of diosgenin 
3.2.4.3 Sarsasapogenin-β-D-glucoside 
Sarsasapogenin-β-D-glucoside 0.01 molL-1 was directly infused via a syringe 
pump immediately prior to the ESI source into ACN-H2O eluent mixtures 
contained 0.01% formic acid (flow rate 200 µLmin
-1
). The ESI inlet was 
maintained at 250°C. Ion responses were determined when the eluent had 
stabilised. It was found that the composition of the eluent had a large effect upon 
the intensity of the fragment ions observed (Figure 3.13). 
 
Figure 3.13. Effect of eluent composition upon the ESI response of 
sarsasapogenin-β-D-glucoside 
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The maximum intensity of [M+H]
+
 m/z 579 occurred at an eluent composition of 
30% ACN. Sarsasapogenin-β-D-glucoside was found to elute in the 60-100% 
ACN portion of the elution gradient when using the 150 x 2.00 mm id, 5 µm, C-
18 reverse phase column. This eluent mixture has an appreciably higher ACN 
proportion than that which would be expected to afford the greatest response. The 
intensity of the m/z 579 [M+H]
+
 ion is ca 280 times higher using 30:70 ACN-H2O 
as eluent than is the case for 100% ACN.  
Direct infusion chromatographic runs at isocratic eluent compositions of 100, 90, 
80, 70, and 60% ACN showed similar trends in ion responses (Figure 3.14). 
 
Figure 3.14. Effect of eluent composition upon the peak area of 
sarsasapogenin-β-D-glucoside 
A theorectical depiction of the estimated increase ionisation that might be 
observed if water was infused post column, prior to the ESI inlet, is depicted in 
Figure 3.15. Disappointing, as was also the case for sarsasapogenin and diosgenin 
(see above), a significant increase in ionisation was not observed for 
sarsasapogenin-β-D-glucoside. 
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Figure 3.15. The estimated effect post column infusion of water would have 
upon ESI reponses of sarsasapogenin-β-D-glucoside 
3.2.5 Capillary Temperature (ESI) 
The capillary temperature was varied as the model compounds were directly 
infused into the eluent stream.  
3.2.5.1 Sarsasapogenin 
The greatest ion current responses for sarsasapogenin when the capillary interface 
was maintained at 300°C Figure 3.16. Data was collected while infusing 0.01 
molL
-1
 sarsasapogenin into an eluent stream of 1:1 ACN-H2O containing 0.01% 
formic acid flowing at 200 µLmin
-1
. 
 
Figure 3.16. Capillary temperature effect upon the ESI responses of 
sarsasapogenin 
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Capillary temperatures below 200-225°C resulted much reduced ion ions, 
presumably due to condensation of sarsasapogenin on the capillary tube. Higher 
temperatures (>300°C) are thought to induce more fragmentation of the analytes 
ions. 
3.2.5.2 Diosgenin 
The ESI capillary temperature was varied as diosgenin was direct infused into the 
eluent stream just prior to the ESI source. The data obtained showed diosgenin, 
like sarsasapogenin, exhibit highest ion currents when the capillary was 
maintained in the vicinity of 300°C (Figure 3.17). Data was collected while 
infusing 0.01 molL
-1
 diosgenin into an eluent stream of 1:1 ACN-H2O containing 
0.01% formic acid flowing at 200 µLmin
-1
. 
 
Figure 3.17. Effect of capillary temperature upon the LCQ ESI response of 
diosgenin 
Lower capillary temperatures result in reduced ion intensity presumably due to 
condensation of diosgenin on the capillary tube while higher temperatures are 
thought to induce more fragmentation of the analyte. Dehydration of the [M+H]
+
 
ion to afford an [M+H-H2O]
+
 ion was more pronounced at 250-275°C than was 
the case for sarsasapogenin, presumably because of the stability of the conjugated 
3,5-diene derivable from diosgenin. A similar tendency towards 3,5-diene 
formation is also observed in GC-MS analyses
25, 49
. 
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3.2.5.3 Diosgenin, LTQ Comparison 
The unexpectably high optimium capillary temperatures (275-325°C) found for 
diosgenin and sarsasapogenin (temperatures in the range 200-250°C are often 
selected as default set-up temperatures) prompted a comparison of the situation 
found for Waikato’s LCQ system with that for an LTQ system avaliable at the 
National Veterinary Institute, Oslo. The comparative study was carried out by 
Professor Wilkins during a three month secondment. 
Remarkably (against expectations of the National Veterinary Institute staff) it was 
found that the ion response continued to rise (appreciably so) until the maximium 
capillary temperature of 400°C was reached. At this temperature ion responses 
were an order of magnetude greater (10 times) than those determined at 250°C 
(Figure 3.18). 
 
Figure 3.18. Effect of capillary temperature upon the LTQ ESI response of 
diosgenin 
It is clear from the data presented in Figure 3.17 and Figure 3.18, that the 
optimum capillary temperature is an instrument dependent value, and that the use 
of moderate capillary temperatures in the range 200-250°C will, at least in the 
case of steroidal sapogenins, reduces the maximum sensitivity of analyses by an 
order of magnitude (10 fold) or more. 
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3.2.5.4 Sarsasapogenin-β-D-glucoside 
The ESI capillary temperature was varied as sarsasapogenin-β-D-glucoside was 
direct infused into the eluent stream just prior to the ESI source. The data obtained 
showed sarsasapogenin-β-D-glucoside was best analysed at capillary temperatures 
around 300°C (Figure 3.19). Data was collected while direct infusing 0.01 molL
-1
 
sarsasapogenin-β-D-glucoside into an eluent stream of 1:1 ACN-H2O containing 
0.01% formic acid flowing at 200 µLmin
-1
. 
 
Figure 3.19. Effect of capillary temperature upon the ESI response of 
sarsasapogenin-β-D-glucoside 
3.2.6 Effect of Eluent Flow Rate upon ESI 
ESI interfaces are reported to show a correlation between the concentration of the 
analyte being sprayed through the interface and the ion intensity observed at the 
detector. Lower detection limits should be obtained at lower flow rates for 
applications utilising an ESI interface. The practical lower limit of the flow rate 
will be constrained by instrument factors (eg minimum stable flow rate, 
chromatographic column requirements, and analysis time). 
The effect flow rate has upon ionisation response using the C-18 column that was 
available in the Chemistry Department at the time this investigation was 
performed by determining the pseudo-molecular ion peak areas at various eluent 
flow rates Figure 3.20-3.21. Analysis was carried out using, 9:1 ACN-H2O 
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containing 0.01% formic acid as eluent, a capillary temperature of 300°C, and at 
flow rates of 200, 300, 400, and 500 µLmin
-1
 respectively. 
In accord with expectations ion responses determined for sarsasapogenin, 
diosgenin and sarsasapogenin-β-D-glucoside reduced as the flow rate was 
increased. An essentially linear decrease in response was observed as the flow 
rates were increased (Figures 3.20-3.22). 
 
Figure 3.20. Effect of flow rate upon the ESI peak area of sarsasapogenin 
 
Figure 3.21. Effect of flow rate upon the ESI peak area of diosgenin ESI 
peak area 
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Figure 3.22. Effect of flow rate upon the ESI peak area of sarsasapogenin-β-
D-glucoside 
The data obtained for the model compounds confirmed the tendency of LC-ESI-
MS to achieve better ionisation efficiency at low flow rates. The increase of 
ionisation at low flow rates would be complemented by the use of (micro or nano) 
columns that operate effectively at low flow rates. 
The modern generation of low flow rate compatible ultra performance liquid 
chromatography (UPLC) columns (as opposed to conventional HPLC columns) 
typically afford good performance at low flow rates due to the effect of having 
small stationary phase  particle size. Provided the solvent system can operate 
satisfactorily at the required flow rate and pressures, the use of low flow rate 
UPLC columns can lead to a substantial increase in sensitivity and 
chromatographic resolution
50, 51
. 
3.3 Atmospheric Pressure Chemical Ionisation Source (APCI) 
APCI is an alternative ionisation technique to ESI that can give significantly 
better detection for particular compounds. APCI is reported to be less influenced 
by matrix effects than ESI, which will benefit the application of APCI in real 
samples
8
. 
The application of LC-MS analysis of the model compounds using the APCI 
interface as the ionisation source were investigated by manipulating ionisation 
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variables to maximise the detected ion responses for the model compounds. Initial 
investigations were performed in both positive and negative modes with direct 
infusion the model compounds into the eluent flow.  
The three model compounds afforded readily identifiable ions in the positive ion 
spectrum, but the negative ion spectrum showed little if any analyte related ion 
responses which were not further investigated. 
3.3.1 Voltage Settings APCI 
The auto tune function of the Thermo Finnigan software ‘LCQ Tune’ was used to 
optimise the ionisation and cone voltages of the APCI inlet and mass spectrometer 
while 0.01 molL
-1
 the model compounds were direct infused into the eluent 
stream prior to the APCI inlet. 
3.3.2 Ionisation Agents (APCI) 
The effect ionisation agents exert upon ionisation of the model compounds were 
investigated by direct infusing 0.001 molL
-1
 of the model compounds into the 
eluent stream just prior to the APCI source analogous to the method used for 
determining the ionisation agents effect in ESI. Three ionisation agents were 
investigated; formic acid, ammonium formate, and ammonium carbonate.  
The APCI source temperature was set to 150°C. Other experimental parameters 
for the collection of the data were as described in (Section 3.2.3) for ESI. 
3.3.2.1 Sarsasapogenin 
Under the chosen APCI condition the sarsasapogenin ionized to a greater extent 
using formic acid or NH4COOH buffers (Figure 3.23). Generally similar ion 
responses were observed when the concentration of formic acid was varied 
(Figure 3.24). 
49 
 
 
Figure 3.23. APCI responses for sarsasapogenin in three ionisation agents 
 
Figure 3.24. Effect of formic acid concentration upon APCI response of 
sarsasapogenin 
3.3.2.2 Diosgenin 
APCI data was collected via direct infusion methods using 1:1 ACN:H2O as the 
eluent at a flow rate of 200 µLmin
-1
 Irrespective of the buffer used diosgenin 
exhibited an appreciable [M+H-H2O]
+
 ion in addition to the desired [M+H]
+
 ion. 
As noted in Section 3.2.5.2 this characteristic can be attributed to the tendency of 
diosgenin to afford a conjugated 3,5-diene via either acid facilitated or thermally 
induced loss of water. 
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Figure 3.25. APCI responses for diosgenin in three ionisation agents 
 
Figure 3.26. Effect of formic acid concentration upon APCI response of 
diosgenin 
3.3.2.3 Sarsasapogenin-β-D-glucoside 
Under the chosen APCI conditions sarsasapogenin-β-D-glucoside showed 
appreciable loss of dehydrated glucose, irrespective of the buffer used (Figure 
3.27). Generally similar total ion currents were observed when the percent of 
formic acid was varied. Some minor variations in the relative contributions of the 
[M+H]
+
, [M+H-glu]
+
 and [M+H-glu-H2O]
+
 ions were noted as the concentration 
of formic acid was varied (Figure 3.28). It was uncertain if these minor variations 
observed were as a result of a trend or inconsistent ionisation currents. 
0
1000000
2000000
3000000
4000000
5000000
6000000
7000000
Formic acid Ammonium 
formate
Ammonium 
bicarbonate
Io
n
 in
te
n
si
ty
 (
co
u
n
ts
/s
)
Diosgenin
ion intensity vs buffer type 
[M+H]+
[M+H-H2O]+
0
2000000
4000000
6000000
8000000
10000000
12000000
14000000
16000000
18000000
0 0.02 0.04 0.06 0.08 0.1
Io
n
 in
te
n
si
ty
 (
co
u
n
ts
/s
)
Percent formic acid (%)
Diosgenin 
[M+H]+
[M+H-H2O]+
51 
 
 
Figure 3.27. APCI responses for sarsasapogenin-β-D-glucoside in three 
ionisation agents 
 
Figure 3.28. Effect of formic acid concentration upon APCI response of 
sarsasapogenin-β-D-glucoside 
3.3.3 Eluent Composition (APCI) 
Eluent composition was varied from 0:100 ACN-H2O to 100:0 ACN- H2O as 
model compounds were directly infused into the eluent stream just prior to the 
APCI source. ACN-H2O eluent containing 0.01% formic acid was used at a flow 
rate of 200 µLmin
-1
 while 0.01 molL
-1
 while sarsasapogenin was infused into the 
eluent via a syringe pump. 
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3.3.3.1 Sarsasapogenin 
The highest [M+H]
+
 ion current was observed for sarsasapogenin when the eluent 
contained 60% ACN (Figure 3.29). This finding parallels that observed using the 
ESI source (Section 3.2.4.1), namely the highest ion current is observed when the 
eluent contains an appreciable percent of water. 
 
Figure 3.29. Effect of eluent composition of upon the APCI response of 
sarsasapogenin 
As noted in Section 3.2.4.1, various options of manipulating the eluent 
composition exist such that sarsasapogenin can be eluted at an eluent composition 
that is beneficial to its ionisation. Options for increasing ionisation include 
changing the chromatographic column to one that causes the target compounds to 
elute in an eluent composition which is beneficial to their ionisation, or post 
column addition of water to the eluent flow. For post column infusion of water the 
consequential increase in ion intensity should be much greater than the decrease 
due to dilution. 
3.3.4 Interface Temperatures (APCI) 
The influence capillary temperature and source heater temperature exerts upon 
ionisation of the model compounds were investigated by directly infusing the 
model compounds into the eluent flow just prior to the APCI interface. Full scan 
mass spectra were acquired when capillary and source temperatures had 
equilibrated at chosen temperatures. Source and capillary temperatures were 
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adjusted between 150-400°C in 50°C increments. Source heater and capillary 
temperatures dependent ion currents are depicted below in three dimensional 
plots. In all cases data was collected under eluent conditions of 200 µLmin
-1
 of 
1:1 ACN-H2O containing 0.01% formic acid as an ionisation agent. 
3.3.4.1 Sarsasapogenin 
Maximum ionisation of sarsasapogenin occurred with a source heater temperature 
around 150°C and capillary temperature in the vicinity of 300-350°C (Figure 
3.30)  
 
Figure 3.30. The effect source heater and capillary temperatures upon the 
APCI response of sarsasapogenin 
The capillary tube is shared by APCI and ESI interfaces and in both cases gave 
optimal pseudo-molecular ion signal intensity at capillary temperatures of ~300°C 
for sarsasapogenin. 
3.3.4.2 Diosgenin 
Maximum ionisation of diosgenin occurred with a source heater temperature 
around 150-200°C and capillary temperature in the vicinity of 200-350°C (Figure 
3.31). Acceptable ionisation currents for diosgenin were observed over a greater 
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range of capillary temperatures (200-350°C) than the case for sarsasapogenin 
(300-350°C). 
 
Figure 3.31. Effect of source heater and capillary temperatures upon the 
APCI response of diosgenin 
3.3.4.3 Sarsasapogenin-β-D-glucoside 
Maximum ionisation of sarsasapogenin-β-D-glucoside occurred with a source 
temperature in the range 200-300°C and capillary temperature in the vicinity of 
250°C (Figure 3.32). 
The source heater temperatures required to achieve maximum sensitivity of 
sarsasapogenin-β-D-glucoside were higher than those observed for either of the 
sapogenins investigated. This can be attributed to the lack of volatility that is 
associated with the glycoside functionality of the saponins. 
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Figure 3.32. Effect of source heater and capillary temperatures upon the 
APCI response of sarsasapogenin-β-D-glucoside 
3.3.5 Effect of Eluent Flow Rate upon APCI 
APCI interfaces are reported to show a correlation between the quantity of the 
analyte being sprayed through the interface and the ion intensity observed at the 
detector. This correlation implies the ion intensity observed will not vary 
significantly as the flow rate of the eluent is varied. 
Contrary to this expectation both sarsasapogenin and its glucoside showed 
essentially linear down trends in their [M+H]
+
 peak area ion responses as the flow 
rate was decreased (Figures 3.33 and 3.34). 
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Figure 3.33. Effect of flow rate of upon the APCI response of 
sarsasapogenin 
 
Figure 3.34. Effect of flow rate upon APCI response of sarsasapogenin-β-D-
glucoside 
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4 LC-MS
n
 Characteristics of Saponins and Sapogenins 
An objective of the investigation reported in this chapter was the identification of 
ESI and APCI mass spectral characteristics, including MS
2
, and MS
3
 parameters, 
that can be applied for the identification of sapogenins, and conjugated analogues 
of these compounds which have an association with hepatogenous photo-
sensitisation diseases of livestock. Ideally, identified parameters should contribute 
to the unequivocal identification of the structures of free and conjugated 
analogues of sapogenins including analogues which have not hitherto been 
reported in the literature. 
To achieve unequivocal identification of analytes the parameters LC-MS
n
 utilises 
for identification including; retention characteristics, MS
n
 fragmentation pathways 
and required collision energies must be investigated. Specifically knowledge of 
MS
n
 fragmentation pattern and appropriate collision energies for an analyte are 
required prior to the implementation of targeted SRM methods utilising either an 
ion trap MS
n
 system, or a triple quad mass spectrometer. LC-MS
n
 utilises 
retention time (chromatographic) data as well as mass spectrometric data for the 
identification of analytes. By chromatographically separating compounds that 
exhibit similar mass spectral characteristics it is possible to achieve unequivocal 
identification of an individual compound. 
GC-MS methods have been used to characterise sapogenins recovered from 
rumen and other GI samples recovered from livestock exhibiting hepatogenous 
photo-sensitisation disease symptoms. GC-MS techniques can be used to 
distinguish the various isomers of sapogenins based on knowledge of the relative 
intensity of selected fragment ions and retention data
16, 26
. These techniques 
cannot be applied to identification of non-volatile conjugated analogues which 
must be hydrolysed to the parent sapogenin prior to GC-MS analyses.  
Since LC-MS analyses are not subject to the requirement requiring hydrolysis of 
the glycoside entity, it was anticipated that it might be possible to define the 
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general structures, if not specific isomeric structural forms, of conjugated 
analogues present rumen and other GI tract samples. 
Once the fragmentation pathways have been mapped variations in MS
n
 
fragmentation characteristics were evaluated in the expectation that, as in GC-MS 
analyses, subtle variations in fragment characteristics and ion intensity ratio may 
serve to distinguish isomeric forms of specific compounds. When selecting 
possible distinguishing ions for use in SRM methods consideration needs to be 
given to their the relative intensity under chosen ESI or APCI conditions since the 
selection of low intensity ions will result in reduced detection limits. 
4.1 Mass Spectral Identification 
For differentiation based upon MS
n 
fragmentation, major fragmentation ions that 
were suitable for SRM analysis were elucidated by mapping the mass 
fragmentation pathways of selected compounds, including, sarsasapogenin, 
diosgenin, episarsasapogenin, smilagenin, tigogenin, and the saponins, 
sarsasapogenin-β-D-glucoside, and sarsasapogenin-β-D-galactoside. 
Fragmentation was mapped for both ESI and APCI inlets, with secondary and 
tertiary fragmentation occurring in the ion trap mass spectrometer (Section 4.4). 
Some deuterated analogues of the sarsasapogenin and episarsasapogenin that had 
been synthesised during previous research were also utilised in the MS
n
 
fragmentation investigations. One such sample was believed to be 20,23,23-
2
H3-
sarsasapogenin while another was believed to be a mixture of 2,2,4,4-
2
H4-
episarsasapogenin and 2,2,4,4-
2
H4-sarsasapogenin mixture. It was not however 
apparent from the information recorded on the historic sample vials if the 
deuterium atoms that were originally introduced at the 20- and 23-positions, or 2- 
and 4- positions respectively, were still present in the historic specimens. 
 A particular concern was that loss of one or more of the deuterium atoms at the 
20- and 23-positions may have occurred post synthesis, given the well established 
tendency of at least the 20,23,23-
2
H3 deuterium atoms to back exchange with 
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water or exchangeable protons in solvents such as methanol
52
. The integrity of the 
historic deuterated samples was therefore established by 
1
H and 
13
C NMR 
analyses prior to the use of these samples in the LC-MS investigations. 
4.2 Confirmation of the Model Compound Integrity by NMR 
1
H and 
13
C NMR assignments established for the dominant components of the 
deuterated samples deuterated samples are presented in Table 4.1. This data 
showed the 20,23,23-
2
H3-sarsasapogenin specimen to be a ca 19:1 mixture of 
20,23,23-
2
H3-sarsasapogenin (25S) and 20,23,23-
2
H3-smilagenin (25R) based 
upon the relative intensities (integration) of the H-26 proton signals. It was also 
determined via the reduced intensities of the C-20 and C-23 signals that the 
20,23,23-
2
H3-sarsasapogenin sample had retained greater than 95% of the three 
20,23,23-deuterium atoms. 
 The NMR data also showed that the 
2
H4-sararsapogenin sample was in fact a ca 
4:1 mixture of 2,2,4,4-
2
H4 episarsasapogenin and 2,2,4,4-
2
H4 sarsasapogenin, as 
determined via integration of the respective H-3 proton signals. Low levels (≤ 5%) 
of some other unidentified sapogenin analogues were detected in each of the 
samples. 
The 
1
H and 
13
C NMR shifts determined for the commercial specimens of 
sarsasapogenin and episarsasapogenin used in the LC-MS investigations (Table 
4.1) corresponded closely to those reported elsewhere for these compounds 
52-54
. 
The commercial sarsasapogenin sample was found to consist of ca 95% 
sarsasapogenin and ca 5% smilagenin, based upon the relative intensities of the 
H-26 proton signals. 
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Table 4.1. 
1
H and 
13
C NMR chemical shifts ( ppm in CDCl3) determined 
for some sapogenins 
 
4.3 Confirmation of Model Compound Integrity by GC-MS  
EI-GC-MS also confirmed the presence of 3 deuteriums in the ring E/F fragment 
ions of 20,23,23-
2
H3-sarsasapogenin which occurred at m/z 141 and 142 compared 
to m/z 139 in sarsasapogenin (Figure 4.1). Similarly the presence of four 
deuterium atoms in the ring A portion of 2,2,4,4-
2
H4-episarsasapogenin and 
2,2,4,4-
2
H4-sarsasapogenin was consistent with the occurrence of fragment ions at 
m/z 259, 277 and 306, compared to m/z 255, 273 and 302 in EI-MS of 
sarsasapogenin and episarsasapogenin (Figure 4.2). 
Sarsasapogenin 20,23,23-
2
H3-Sarsasapogenin Episarsasapogenin 2,2,4,4-
2
H4-Episarsasapogenin
Carbon
13
C 
1
H 
13
C 
1
H 
13
C 
1
H 
13
C 
1
H 
C1 30.0 1.39, 1.50 30.0 1.41, 1.50 35.4 0.94, 1.77 35.2 0.95, 1.78
C2 27.8 1.45, 1.60 27.9 1.42, 1.47 30.5 1.30, 1.65 ** **
C3 67.1 4.10 67.1 4.11 71.7 3.60 71.6 3.62
C4 33.6 1.32, 1.97 33.6 1.32, 1.98 36.5 1.50, 1.75 ** **
C5 36.6 1.72 36.6 1.73 42.1 1.38 41.9 1.38
C6 26.6 1.16, 1.90 26.6 1.14, 1.91 26.7 1.09, 1.43 27.1 1.27, 1.89
C7 26.6 1.07, 1.40 26.6 1.04, 1.39 27.1 1.24, 1.85 26.6 1.32, 1.45
C8 35.3 1.59 35.2 1.80 35.5 1.56 35.5 1.59
C9 39.9 1.32 39.9 1.32 40.6 1.40 40.6 1.42
C10 35.3 * 35.2 * 34.7 * 34.7 *
C11 20.9 1.30,1.38 20.9 1.25, 1.39 20.6 1.24, 1.38 20.6 1.25, 1.38
C12 40.3 1.15, 1.71 40.4 1.15, 1.72 40.3 1.14, 1.71 40.3
C13 40.7 * 40.7 * 40.7 * 40.7 *
C14 56.5 1.16 56.5 1.17 56.4 1.14 56.4 1.16
C15 31.8 1.23, 1.94 31.8 1.23, 1.98 31.8 1.23, 1.97 31.8 1.21, 1.99
C16 81.0 4.40 81.1 4.40 81.0 4.39 81.0 4.40
C17 62.1 1.76 62.0 1.77 62.1 1.75 62.0 1.75
C18 16.5 0.76 16.5 0.76 16.5 0.74 16.5 0.77
C19 23.9 0.97 24.0 0.98 23.4 0.92 23.4 0.94
C20 42.2 1.81 42.1 ** 42.1 1.79 42.1 1.82
C21 14.4 0.99 14.2 0.98 14.3 0.97 14.4 0.99
C22 109.8 * 109.7 * 109.7 * 109.8 *
C23 26.0 1.39, 1.87 25.7 ** 26.0 1.38, 1.86 26.0 1.40, 1.85
C24 25.8 1.39, 2.02 25.6 1.39, 2.01 25.8 1.38, 2.02 25.8 1.40, 2.04
C25 27.1 1.69 27.1 1.68 27.1 1.67 27.1 1.71
C26 65.2 3.3, 3.96 65.2 3.29, 3.95 65.1 3.28, 3.73 65.1 3.35, 3.95
C27 16.1 1.07 16.1 1.08 16.1 1.07 16.1 1.07
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Figure 4.1. Plausible structures for the m/z 139 ion and deuterated analogues 
of these ions observed in the EI-MS of sarsasapogenin  
 
Figure 4.2. Plausible structures for the m/z 302, 273 and 255 ions, and 
deuterated analogues of these ions observed in the EI-MS of sarsasapogenin 
4.4 MSn Fragmentation of the Model Compounds 
By comparing the spectra of sarsasapogenin and episarsasapogenin with the 
available deuterated analogues, 20,23,23-
2
H3-sarsasapogenin and 2,2,4,4-
2
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compound that ion fragments originated from could be elucidated based upon the 
observation of a mass increase or no mass increase for the fragment ions of the 
deuterated analogues. An attempt was made to propose structures of the major 
fragment ions which are consistent with the data observed (Sections 4.4.4 and 
4.4.11). 
The effect collision energy in the ion trap had upon the fragmentation of various 
sapogenins was investigated prior to obtaining the mass spectral fragmentation 
pathways. It was found using collision energies of approximately 30% gave 
complete fragmentation of the parent ion in the ion trap without causing excessive 
fragmentation. 
To improve the ease of following the fragmentation processes, a convention has 
been adopted where by ions originating in the full scan mass spectrum are 
indicated in bold in the description of the fragmentation processes. 
4.4.1 Fragmentation of Sarsasapogenin (ESI) 
The fragmentation of sarsasapogenin was investigated by direct infusion of 0.001 
molL
-1
 solution of sarsasapogenin solution into the eluent flow via a syringe 
pump. The following ionisation conditions were used: capillary temperature of 
250°C, 1:1 ACN-H2O eluent containing 0.01% formic acid as an ionisation 
buffer/aid was eluted at a flow rate of 200 µLmin
-1
. 
 
Figure 4.3. Full scan ESI mass spectrum of sarsasapogenin 
The full scan mass spectrum of sarsasapogenin showed ions at m/z 458 (weak), 
417, 399, 381 (weak), 273, and 255. No high mass [M2+H]
+
or [M3+H]
+
 cluster 
ESIsarsaACNH2O29509 #761-863 RT: 57.32-60.32 AV: 103 NL: 2.05E6
F: + c ESI Full ms [ 150.00-2000.00]
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ions were observed. Secondary fragmentation of ions seen in the full scan MS 
were investigated using a collision energy of 30% to determine MS
2
 and MS
3
 
spectra. 
The weak m/z 458 ion is attributed to the mono solvated [M+ACN+H]
+
 pseudo-
molecular ion. The intensity of this ion was too low to permit its MS
2
 spectrum to 
be determined. 
The m/z 417 ion is attributable to the [M+H]
+
 pseudo-molecular ion of 
sarsasapogenin. MS
2
 fragmentation of this ion afforded m/z 399, 381, 273, and 
255 ions. The m/z 399 ion can be attributed to the loss of water (dehydration) from 
the pseudo-molecular ion. MS
3
 (m/z 417 → m/z 399) fragmentation of this ion 
predominantly afforded an afforded m/z 273 ion and to a lesser extent an m/z 381 
ion. MS
3
 (m/z 417 → m/z 273) fragmentation of the m/z 273 ion afforded an m/z 
255 ion as a result of the loss of water (dehydration) and low intensities fragment 
ions at m/z 227, 213, 199, 173, 159, 147, 145, 133 and 121. MS
3
 (m/z 417 → m/z 
255) fragmentation of the m/z 255 ion also afforded m/z 227, 213, 199, 173, 159, 
147, 145, 133 and 121 fragment ions.  
MS
2
 fragmentation of the m/z 399 observed in the full scan MS of sarsasapogenin 
afforded ions at m/z 381, 285, and 255. MS
2
 fragmentation of the m/z 381 ion 
observed in the full scan MS of sarsasapogenin predominantly fragmented to 
afford an m/z 255 ion together with a low intensity m/z 363 ion. 
MS
2
 fragmentation of the m/z 273 ion observed in the full scan MS of 
sarsasapogenin predominantly fragmented to afford an m/z 255 ion together with 
lower intensity m/z 199 and 159 ions. The loss of 18 amu from m/z 273 →m/z 255 
can be attributed to dehydration (water loss) occurring. The MS
3
 (m/z 273 → m/z 
255) afforded m/z 227, 213, 199, 173, 159, 147, 145, 133, and 121 ions analogous 
to those observed via the MS
3
 (m/z 417 → m/z 273) pathway. 
The fragmentation pathways observed for sarsasapogenin using an ESI inlet 
coupled to an advantage LCQ (ion trap) mass spectrometer are summarised in 
Figure 4.4. 
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Figure 4.4. ESI Fragmentation tree for sarsasapogenin 
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m/z 189 and 
173. 
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4.4.2 Fragmentation of 2,2,4,4-2H4-episarsasapogenin (ESI) 
The MS
n
 fragmentation of an 80:20 mixture of 2,2,4,4-
2
H4-episarsasapogenin and 
2,2,4,4-
2
H4-sarsasapogenin was determined using the direct infusion conditions 
described above for sarsasapogenin. 
4 
2
O
O
HO
23
3
20
D D
D
D
 
Figure 4.5. Structure of 2,2,4,4-
2
H
4
-episarsasapogenin 
 
Figure 4.6. Full mass spectrum of 2,2,4,4-
2
H4-episarsasapogenin 
The full scan MS of the 80:20 mixture of 2,2,4,4-
2
H4-episarsasapogenin and 
2,2,4,4-
2
H4-episarsasapogenin, recorded in direct infusion mode, showed a strong 
m/z 421 ion and lower intensity 422, 404, 403, 385, 289, 278, 277 and 259 ions. 
A complicating factor, often encountered with ion trap MS systems is that when 
high concentrations of ions are present in the trap, space charging effects arising 
from mutual charge repulsion effects between ions become significant. This 
results in the need for higher than expected potential (voltage) is required to expel 
the entire population of target ion from the trap. Thus a [M+H]
+
 ion which, at low 
concentration, appears (say) at m/z 421.5, will occur at progressively higher and 
higher nominal mass (eg m/z 421.7, 421.9, 422.1, etc) as the concentration of ions 
in the trap is increased. Notwithstanding this issue MS
2
, MS
3
, MS
n
 spectra of an 
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ion that was initially subject to a modest space charging effect affords the correct 
nominally masses for it daughter ions since only a low level of ions are retained in 
the trap during MS
n
 steps and space charging effects are not significant. 
The apparent presence of an m/z 421.42 ion in the full scan MS of 2,2,4,4-
2
H4-
episarsasapogenin presented in Figure 4.6, as opposed to an expected m/z 421 ion, 
can be attributed to the high concentration of ions present in the trap when the 
direct infusion full scan MS spectrum was recorded. Quadrupole EI-MS spectra 
are not prone to space charging effects, since this type of MS system generates 
ions on the fly and does not trap a high concentration of ions in its source area. 
The correct [M+H]
+
 ion mass (m/z 420) was observed for the 2,2,4,4-
2
H4-
episarsasapogenin sample when it was examined using EI-GC-MS. 
Since the mass of these ions (excluding isotope ions and ions whose masses 
appear to have been inflated by space charging effects: see above) are four amu 
greater than the m/z 417, 381, 285, 273, and 255 ions observed for sarsasapogenin 
or episarsasapogenin ions it can be reasoned they all contain the ring-A portion of 
the genin structure. 
The m/z 421 ion is attributable to the pseudo-molecular [M+H]
+
 ions of 2,2,4,4-
2
H4-episarsasapogenin and 2,2,4,4-
2
H4-episarsasapogenin. MS
2
 fragmentation of 
this ion afforded ions at m/z 403 (water loss), 385, 277, and 259. MS
3
 (m/z 421 → 
m/z 277) fragmentation afforded to an m/z 259 ion attributable to the loss of a 
water molecule. The m/z 403 ion observed in the full scan MS spectrum 
fragmented under MS
2
 conditions to afford m/z 385, 367, 329, 289, 259, and 221 
ions while the m/z 277 ion observed in the full scan MS spectrum fragmented to 
predominantly afford m/z 259 ions. MS
3
 (m/z 277 → m/z 259) fragmentation 
afforded ions at m/z 231, 203, 174, 173, 159, and 157 ions. 
The m/z 259 ion observed in the full scan fragmented to afford m/z 231, 217, 203, 
189, 187, 173, 163, 159, 147, and 145 ions. The MS
2
 (m/z 259) and MS
3
 (m/z 277 
→ m/z 259) fragmentation patterns of the deuterated m/z 259 ion appears to be 
more complex than that observed corresponding non-deuterated m/z 255 ion of 
sarsasapogenin. 
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Figure 4.7. ESI fragmentation tree for 2,2,4,4-
2
H4-episarsasapogenin 
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4.4.3 Fragmentation of 20,23,23-2H3-sarsasapogenin (ESI) 
The fragmentation of 20,23,23-
2
H3-sarsasapogenin was investigation in direct 
infusion mode under the same conditions as those described above for 
sarsasapogenin. 
4 
2
O
O
HO
23
D
DD
3
20
 
Figure 4.8. Structure of 20,23,23-
2
H3-sarsasapogenin 
 
Figure 4.9. Full ESI mass spectrum of 20,23,23-
2
H3-sarsasapogenin 
The full scan mass spectrum was dominated by ion clusters centred at m/z 461, 
421 and 403 together with low intensity m/z 274, 273, and 255 ions.  
The apparent presence of an m/z 420.43 ion in the full scan MS of 20,23,23-
2
H3-
sarsasapogenin presented in Figure 4.9, as opposed to an expected m/z 420 ion, 
can be attributed to the high concentration of ions present in the trap when the 
direct infusion full scan MS spectrum was recorded (space charging). The correct 
[M+H]
+
 ion mass (m/z 419) was observed for the 20,23,23-
2
H3-sarsasapogenin 
sample when it was examined using EI-GC-MS. 
 
MS
2
 fragmentation of the space charged m/z 418-422 ion cluster predominately 
afforded an m/z 403 ion and a less intense m/z 273 ion. MS
2
 fragmentation of the 
m/z 273 ion observed in the full scan MS spectrum predominantly an m/z 255 ion 
attributable to water loss. MS
3
 (m/z 420 → m/z 255) fragmentation afforded m/z 
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199, 173, 159, 145, and 131 ions analogous to those observed in the MS
2
 (m/z 
255) spectrum. The space charged m/z 459-461 ion cluster can be attributed to 
formation of a solvated [M+ACN+H]
+
 pseudo-molecular ion. 
The MS
2 
fragmentation of the m/z 402 ion cluster to predominately afforded an 
m/z 255 ion together, with lesser intensity ion fragments at m/z 384, 383, 382, 
285, and 218. MS
2
 fragmentation of the m/z 273 ion predominantly afforded an 
m/z 255 (water loss) ion. MS
2
 fragmentation of the m/z 255 ion afforded ions at 
m/z 227, 213, 199, 187, 185, 173, 171, and 159. It is apparent from the MS
n
 data 
determined for sarsasapogenin, and its 20,23,23-deuterated analogue, that none of 
foregoing ions with exception of the m/z 402 ion are deuterated, and that they 
appear to include the ring A/B portion, but not the ring D/F portion of 20,23,23-
2
H3-sarsasapogenin. The m/z 402 ion was observed to afford an m/z 383 ion as a 
result of the loss of HOD (19 amu). 
 
Figure 4.10. ESI fragmentation tree of 20,23,23-
2
H3-sarsasapogenin 
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4.4.4 Plausible Structures for Major ESI Fragment Ions of 
Sarsasapogenin 
Plausible structures for the dominant ions seen in the full scan, MS
2
 and MS
3
 ESI 
spectra of sarsasapogenin, 20,23,23-
2
H3-sarsasapogenin and 2,2,4,4-
2
H4-
episarsasapogenin/ 2,2,4,4-
2
H4-sarsasapogenin are presented below. For each of 
these compounds protonation of any of three oxygen atoms would afford the 
pseudo-molecular ions as illustrated in Figure 4.11 for sarsasapogenin ([M+H]
+
 at 
m/z 417). Thereafter loss of a water molecule occurs, either in the ESI interface, or 
under MS
2
 conditions in the ion trap to form an m/z 399 ion. 
O
O
HO
O
O
HO
O
O
HO
H
+
H
+
H
+
ion a, m/z 417 ion b, m/z 417 ion c, m/z 417  
Figure 4.11. Plausible sarsasapogenin pseudo-molecular ion structures 
In the ion trap the loss of water was determined, at least in part, to involve the loss 
of a ring E or F oxygen atom since the dominant fragment in the (m/z 417→ m/z 
399) MS
3
 spectrum was the m/z 273 ion. The m/z 417→ m/z 399 MS3 spectrum 
also included an m/z 381 ion, corresponding to the loss of a second water 
molecule. The proposed m/z 273 ion structure (based on that advanced by 
Blunden et al
26
, Figure 4.13) requires the presence of the 3-hydroxyl group. 
In contrast to the fragmentation characteristics of the m/z 399 ion formed in the 
ion trap under MS
2
 conditions from the full scan m/z 417 [M+H]
+
 ion (Figure 
4.11), the full scan m/z 399 ion formed in the ESI interface fragmented under MS
2
 
conditions to afford an m/z 255 ion (rather than an m/z 273 ion). 
Based the foregoing observations it can be inferred that the full scan m/z 399 ion 
formed in the ESI interface arise as a result of dehydration of the C-3 hydroxyl 
group to form the corresponding 2-ene or 3-ene. (Figure 4.12). The fragmentation 
process of the plausible structures for major ions observed have been summarised 
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in Figure 4.13. The proposed formation of the 2-ene or 3-ene analogues upon 
dehydration at C3 are consistent with the fragments proposed by Griffiths for the 
3-hydroxy-20-keto-steroid oximes
55, 56
. 
The occurrence of the deuterated variant of the m/z 273 and 255 ions observed for 
sarsasapogenin at m/z 277 and m/z 259 after water loss in equivalent spectra of 
2,2,4,4-
2
H4-episarsasapogenin shows (at least in the case of the latter molecule) 
that none of the C-2 or C-4 deuterium atoms are lost upon dehydration at C-3.  
Based upon this observation it can be reasoned for 2,2,4,4- episarsasapogenin, and 
by implication also sarsasapogenin, dehydration at C-3 procedures either via the 
loss of the 3-OH group and a more remote proton (eg H-1 or H-5 to afford 1,3- or 
3,5-cyclo analogues respectively), or by loss of the 3-OH group and H-3, 
accompanied by migration of a hydrogen (or deuterium) atom from C-2 to C-3 to 
afford a 2-ene or from C-4 to C-3 to afford 3-ene structure respectively. Only the 
latter possibility is depicted in the Figure 4.13. Many plausible structures exist for 
the various ion fragments observed. For ease of depiction only one option has 
been shown in the fragmentation sequence proposed for sarsasapogenin. 
 
Figure 4.12. Plausible C-3 dehydration structures 
3-ene 2-ene 3(5)-cyclic 1(3)-cyclic
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Figure 4.13. Plausible pathways to m/z 399, 273 and 255 ions observed for 
sarsasapogenin 
At the MS
2
 level the m/z 417 → m/z 399, m/z 417 → 273 or m/z 417 → m/z 255 
ion transitions were the dominant pathways. Provided buffer, ionisation and 
capillary interface conditions are chosen to optimise the intensity of the m/z 417 
ion in full scan mode, the foregoing ion transitions are those which would afford 
the greatest sensitivity in ion trap MS
2
 or triple quad SRM analyses. 
MS
2
 and MS
3
 fragmentation data determined for 20,23,23-
2
H3 sarsasapogenin and 
the 80:20 mixture of 2,2,4,4-
2
H3- sarsasapogenin and episarsasapogenin (Sections 
4.2 and 4.3) were consistent with the structure(s) proposed for the m/z 273 ion and 
its dehydrated m/z 255 analogue (Figure 4.13). Specifically the incorporation of 
four deuterium atoms at the C-2 and C-4 increased the mass to the by four amu so 
that it occurred at m/z 277 and m/z 259 respectively, while the incorporation three 
deuterium atoms at the C-20 and C-23 position did not alter the mass of this ion.  
The possibly exists that either or both of these deuterated analogues could be used 
as internal standards in future SRM based LC-MS
n
 analysis of sapogenins present 
in rumen and other extracts. Suitable SRM ion transitions would be m/z 417 → 
m/z 399, or m/z 417 → m/z 273 for natural sapogenins and m/z 421 → m/z 403 or 
m/z 421 → m/z 277 for 2,2,4,4-2H4-sarsasapogenin or sarsasapogenin as internal 
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standards. The use 20,23,23-
2
H3 analogues as internal standards are not 
considered to be as suitable given the documented tendency of these deuterium 
atoms to back exchange with hydrogen atoms in aqueous environments
52
. 
4.4.5 Fragmentation of Sarsasapogenin (APCI) 
The APCI MS characteristics of sarsasapogenin were investigated by direct 
infusion of 0.001 molL
-1
 solution of sarsasapogenin solution into an 1:1 ACN-
H2O eluent flow via a syringe pump. The eluent contained 0.01% formic acid. 
30% collision energy was used to obtain MS
2
 and MS
3
 spectra. The APCI heater 
and capillary temperature were set to 250° C. Subsequent data showed that these 
inlet conditions were far from optimal (Section 3.3.4).  
 
Figure 4.14. Full scan APCI mass spectrum of sarsasapogenin 
The full scan APCI mass spectrum showed ions resulting from sarsasapogenin at; 
m/z 417, 399, 285, 273, and 255, analogous to ions observed under ESI 
conditions. Secondary fragmentation of these ions was investigated using MS
2
 
and MS
3
 spectra where ion intensities permitted. 
The m/z 417 ion is attributed to the pseudo-molecular ion of sarsasapogenin, 
[M+H]
+
. Under MS
2
 conditions the m/z 417 ion fragmented to afford to m/z 399 
(water loss), 273, and 255 ions. The MS
3
 (m/z 417 → m/z 273) predominantly 
afforded a m/z 255 ion. The MS
2
 fragmentation m/z 255 ion, which was also 
observed in the full scan APCI spectrum, afforded m/z 213, 199, 173, 159, and 
131 ions. 
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The m/z 399 ion is attributed to the mono dehydration product of sarsasapogenin, 
[M–H2O+H]
+
. The MS
2
 of the m/z 399 ion afforded m/z 381, m/z 285, and m/z 255 
ions. The MS
3
 fragmentation of the m/z 399 →m/z 381 ion fragmented 
predominantly afforded a m/z 255 ion and a lesser quantity of a m/z 363 (water 
loss ion). MS
2
 fragmentation of the m/z 273 ion observed in the full scan APCI 
spectrum also predominantly afforded an m/z 255ion which under MS
3
 conditions 
(m/z 273 → m/z 255) fragmented to afford ions at m/z 199, 173, 159, 147, and 
131. 
APCI MS
2
 and MS
3
 fragmentation pathways (Figure 4.8) were generally similar 
to those observed under ESI conditions (Section 4.4.1). 
 
Figure 4.15. APCI fragmentation tree for sarsasapogenin  
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4.4.6 Fragmentation of 2,2,4,4-2H4-episarsasapogenin (APCI) 
Under full scan APCI conditions 2,2,4,4-
2
H4-episarsasapogenin afforded ions at 
m/z 421, 403, 385, 289, 277, and 259. As all the ion fragments have increased in 
mass by four amu from the ion fragments seen for sarsasapogenin, it can be 
reasoned that they included the deuterated ring A portion of molecule. 
The m/z 421 ion is attributed to the pseudo-molecular ion of 2,2,4,4-
2
H4-
episarsasapogenin, [M+H]
+
. Under MS
2
 conditions the m/z 421 ion fragmented to 
afford m/z 403, 277, and 259 ions. These ions are considered to be the deuterated 
counterparts of the m/z 399, 273 and 255 ions observed in both the ESI and APCI 
spectra of sarsasapogenin (Sections 4.4.1 and 4.4.5). 
In general APCI MS
2
 and MS
3
 fragmentation pathways observed for 2,2,4,4-
2
H4-
episarsasapogenin were similar to those observed under ESI conditions for this 
compound (Section 4.4.2). 
4.4.7 Fragmentation of 20,23,23-2H3-sarsasapogenin (APCI) 
The APCI fragmentation of 20,23,23-
2
H3-sarsasapogenin was investigated under 
similar conditions to those described for sarsasapogenin and 2,2,4,4-
2
H4 
episarsasapogenin. 
 
Figure 4.16, Full APCI mass spectrum of 20,23,23-
2
H3-sarsasapogenin 
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The full mass spectrum showed ion clusters resulting from 20,23,23-
2
H3-
sarsasapogenin at; m/z 459-461, 420, 418-421, 400-403 383-385, 286-287, 273-
275 and 255-257. Secondary fragmentation of the fragment ions of 20,23,23-
2
H3-
sarsasapogenin was investigated using MS
2
 and MS
3
 spectra where ion intensities 
permitted.  
The m/z 420, 419, and 418 ions are attributed to the pseudo-molecular ion of 
triply, doubly, and singly deuterated sarsasapogenin respectively. This data 
indicates that some of the deuterium in the 20,23,23-
2
H3-sarsasapogenin may have 
been exchanged with protons in the aqueous eluent prior to the sample material 
entering the mass spectrometer either during passage through the LC column in 
the presence of water and the formic acid buffer containing eluent, or during the 
flash vaporisation section of the APCI inlet prior the vaporised material entering 
the mass spectrometer via its capillary inlet. The ESI inlet does not utilise a flash 
vaporisation step.  
The manner in which the m/z 459-461 [M+ACN+H]
+
, 418-421 [M+H]
+
, 400-403 
[M-H2O+H]
+
 383-385, 286-287, 273-275 and 255-257 ion clusters observed in 
the full scan MS of 20,23,23-
2
H3 sarsasapogenin fragmented under MS
2
 and 
subsequently MS
3
 conditions were similar to those determined under ESI 
conditions (Section 4.4.3), taking into the account the apparent loss (back 
exchange with the protons in the aqueous eluent) during the flash vaporisation 
stage of the APCI inlet. 
4.4.8 Summary of APCI Fragmentation of Sarsasapogenin 
By comparing the APCI fragmentation of sarsasapogenin with its deuterated 
analogues it is possible to assign plausible structures for some of the major ion 
fragments. Other than an increase in fragmentation in the full mass spectra relative 
to ESI the fragmentation pathways appeared to be identical to those observed for 
ESI. Based upon these observations it is proposed the main ion fragments 
produced for sarsasapogenin using an APCI interface are analogous to those of the 
ESI interface (Figures 4.11 to 4.13). 
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4.4.9 Fragmentation of Diosgenin (ESI) 
The ESI fragmentation patterns of diosgenin were investigated under similar 
conditions to those used for the determination of fragmentation patterns for the 
previous sapogenins. 
 
Figure 4.17. Full scan ESI mass spectrum for diosgenin 
The mass spectrum showed ions resulting from diosgenin at; m/z 431, 415, 397, 
379, 271, and 253. Secondary fragmentation of these ions was investigated using 
MS
2
 and MS
3
 spectra where ion intensities permitted. Nominal collision energy of 
30% was used during obtaining all the MS
2
 and MS
3
 spectra. 
The weak m/z 431 ion is probably attributable to [M+H]
+
 ion of a low level of a 
hydroxylated analogue of diosgenin, rather than to the formation of [M+CH4+H]
+
 
or [M+O+H]
+ 
ions. 
The m/z 415 ion is attributed to the pseudo-molecular ion of diosgenin, [M+H]
+
. 
The MS
2
 (m/z 415) ion fragmented to ions at m/z 397, 379, 283, 271, and 253. The 
m/z 415 → m/z 397 is a result of loss of water (dehydration) from the pseudo-
molecular ion. The MS
3
 (m/z 415 → m/z 397) fragments gave a spectrum 
containing predominantly m/z 271 ions. Ion intensities were too low to permit 
spectra of MS
3
 (m/z 415 → m/z 379) MS3 (m/z 415 → m/z 283) to be observed. 
The MS
3
 (m/z 415 → m/z 271) fragmented to predominantly the m/z 253 ion as a 
result of loss of water (dehydration), with smaller ion fragments of low intensities 
at m/z 225, 211, 197, 171, 157, 147, 145, 133, and 121. The MS
3
 (m/z 415 → m/z 
253) fragmented to ions consistent with those observed in the MS
2
 (m/z 253) 
spectra, namely m/z 225, 211, 197, 183, 171, and 157 ions. 
ESI diosegen fragmentation #1-518 RT: 0.02-0.24 AV: 12 NL: 1.69E6
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The m/z 397 ion is attributed to the mono dehydration product of diosgenin, [M–
H2O+H]
+
. The MS
2
 (m/z 397) fragmented to ions at m/z 379, 361, 283, 253, and 
215. The MS
3
 (m/z 397 → m/z 379) fragmented predominantly to ions at m/z 361 
with a lesser quantity of m/z 253. The MS
3
 (m/z 397 → m/z 253) fragmented to 
ions consistent with those observed in the MS
2
 (m/z 253) spectrum, with m/z 225, 
211, 197, 171, 157, 145, 143, and 131 ions. The MS
2
 (m/z 381) fragmented to 
predominantly the ion m/z 253, with lesser amounts of the m/z 361 ion. 
The MS
2
 (m/z 271) predominantly gave the ion fragment m/z 253 with lesser 
quantities of smaller fragments at, m/z 225, 211, 197, 183, 171, and 157. The loss 
of 18amu from m/z 271 → m/z 253 can be attributed to loss of water 
(dehydration). The MS
3
 (m/z 271 → m/z 253) gave fragment ions at m/z 225, 211, 
197, 183, 171, and 157 ions. 
The ion fragment at m/z 253 seems to be a fairly stable ion fragment that most of 
the ions seen in the full MS eventually can be fragmented to. The MS
2
 (m/z 253) 
resulted in ions at m/z 238, 225, 211, 197, 183, 171, 157, 145, and 143. The weak 
MS
3 
(m/z 253 → m/z 197) spectra suggested the fragments include, m/z 182, 169, 
and 155. The weak MS
3 
(m/z 253 → m/z 171) spectra suggested the fragment m/z 
143 ions. 
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Figure 4.18. ESI fragmentation tree for diosgenin 
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4.4.10 Fragmentation of Diosgenin (APCI) 
Conditions used for the determination of the APCI fragmentation patterns of 
diosgenin were similar to those used for the determination of APCI fragmentation 
patterns for the previous sapogenins in this investigation. 
The mass spectrum showed ions resulting from diosgenin at; m/z 415, 397, 379, 
and 253. Secondary fragmentation of these ions was investigated using MS
2
 and 
MS
3
 spectra where ion intensities permitted. Nominal collision energy of 30% 
was used during obtaining all the MS
2
 and MS
3
 spectra. 
The m/z 415 ion is attributed to the pseudo-molecular ion of diosgenin, [M+H]
+
. 
The MS
2
 (m/z 415) ion fragmented primarily to the ion at m/z 271 with lesser 
intensity ions of m/z 397, 379, 283, 253, 211, 172, and 157. In the MS
2
 (m/z 415), 
m/z 397 is a result of loss of water (dehydration) from the pseudo-molecular ion.. 
The MS
3
 (m/z 415 → m/z 271) fragmented to give predominantly the m/z 253 ion 
as a result of loss of water (dehydration), with smaller ion fragments of low 
intensities at m/z 225, 213, 211, 197, 171, 159, and 157. The MS
3
 (m/z 415 → m/z 
253) fragmented to ions at m/z 211, 197, 183, and 155. 
The m/z 397 ion is attributed to the mono dehydration product of diosgenin, [M–
H2O+H]
+
. The MS
2
 (m/z 397) fragmented predominantly to m/z 253 with lesser 
intensity ion fragments at m/z 379, 361, 283, 215, 171, and 157. The MS
3
 (m/z 
397 → m/z 253) fragmented to ions consistent with those observed in the MS2 
(m/z 253) spectrum, specifically m/z 225, 224, 211, 197, 185, 183, 173, 171, 169, 
159, and 157 ions. The MS
2
 (m/z 379) gave predominantly the ion fragment m/z 
253, with lesser amounts of the m/z 361 ion. 
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Figure 4.19. APCI fragmentation tree for diosgenin 
4.4.11 Summary of Fragmentation of Diosgenin 
The fragmentation patterns observed for diosgenin under both ESI and APCI are 
consistent with the fragmentation patterns observed for sarsasapogenin with the 
exception of two mass units difference due to the 5-ene in diosgenin. Based upon 
the fragmentation observed a plausible structural fragmentation sequence for 
diosgenin was proposed based on those proposed in Section 4.4.4 for 
sarsasapogenin (Figure 4.20). 
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Figure 4.20. Plausible pathways to m/z 397, 271 and 253 ions for diosgenin 
4.4.12 Fragmentation of Sarsasapogenin-β-D-glucoside (ESI) 
The conditions used for the generation of ESI fragmentation patterns data for 
sarsasapogenin-β-D-glucoside were similar to those used above for the 
determination of ESI patterns of sapogenins.  
 
Figure 4.21. Full scan ESI mass spectrum of sarsasapogenin-β-D-glucoside 
The mass spectrum showed ions resulting from sarsasapogenin-β-D-glucoside at; 
m/z 579, 417, 399, 273, and 255. Fragmentation of these ions was investigated 
using MS
2
 and MS
3
 spectra where ion intensities permitted. 
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The m/z 579 ion is attributed to the pseudo-molecular ion of sarsasapogenin-β-D-
glucoside [M+H]
+
. The MS
2
 (m/z 579) fragmented to ions at m/z 435, 417, 399, 
381, 285, 273, 255 and 173. MS
3
 (m/z 579→m/z 435) resulted in the observation 
of fragments at m/z 273, and 255. The MS
3
 (m/z 579 → m/z 417) fragmented to an 
ion at m/z 273. The MS
3
 (m/z 579 → m/z 399) fragmented to ions at m/z 255 and 
381. The MS
3
 (m/z 579 → m/z 273) fragmented to ions at m/z 255, 147, and 159. 
The ion fragment of MS
3
 (m/z 579 → m/z 255) fragments to ions consistent with 
those observed in the MS
2
 (m/z 255) of sarsasapogenin, namely m/z 227, 213, 199, 
187, 185, 173, 159, 147, 145, and 133 ions.  
The m/z 417 ion is attributed to the pseudo-molecular ion of sarsasapogenin, 
[sapogenin+H]
+
, and is a result of the loss of a dehydrated glucose unit (162 amu) 
from the sarsasapogenin-β-D-glucoside pseudo-molecular ion. The MS2 (m/z 417) 
ion fragmented to ion fragments m/z 399, 285, 273, and 255. The MS
3
 (m/z 417 → 
m/z 273) fragmented predominantly to the m/z 255 ion with traces of m/z 227, 
199, 185, 173, 159, 147, 145, 133, and 121 ions observed. The MS
3
 (m/z 417 → 
m/z 255) fragments to ions consistent with those observed in the spectra of MS
2
 
(m/z 255) of sarsasapogenin, namely m/z 227, 213, 199, 185, 173, 159, 147, 145, 
133, and 121 ions. 
The m/z 399 ion is attributed to the mono dehydration product of sarsasapogenin, 
[sapogenin–H2O+H]
+
, and is the result of the loss of a glucose unit (180 amu) or 
the loss of a dehydrated glucose unit and the loss of one water molecule, from the 
sarsasapogenin-β-D-glucoside pseudo-molecular ion. The MS2 (m/z 399) 
fragmented to ions at m/z 381, 285, 255, and 159. The MS
3
 (m/z 399 → m/z 381) 
fragmented to m/z 255, the ion response observed was weak. The ion fragment 
MS
3
 (m/z 399 →m/z 255) fragments to ions consistent with those observed in the 
MS
2
 (m/z 255) spectrum of sarsasapogenin, with m/z 227, 213,199, 187, 185, 173, 
161, 159, 147, 145, 133, 131, 121, and 105 ions. The foregoing fragmentation 
pathways for the ions of m/z 417 or lower were essentially identical to those 
observed for sarsasapogenin. 
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Figure 4.22. ESI fragmentation tree for sarsasapogenin-β-D-glucoside 
4.4.13 Fragmentation of Sarsasapogenin-β-D-glucoside (APCI) 
The conditions used for the generation of APCI fragmentation patterns data for 
sarsasapogenin-β-D-glucoside were similar to those used for the determination of 
APCI fragmentation patterns of sapogenins. 
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Figure 4.23. Full scan APCI mass spectrum of sarsasapogenin-β-D-
glucoside 
The mass spectrum showed ions resulting from sarsasapogenin-β-D-glucoside at 
m/z 579, 458, 417, 399, 386, 273, and 255. Secondary fragmentation of these ions 
was investigated using MS
2
 and MS
3
 spectra where ion intensities permitted. 
The APCI interface induced a larger degree of fragmentation than ESI resulting in 
the observation of more ion fragments relative to the pseudo-molecular ion. As 
with ESI the ion fragments seen at m/z 417 and lower are consistent with those 
ions seen for the saponin component, sarsasapogenin (Section 4.4.5). 
The m/z 579 ion is attributed to the pseudo-molecular ion of sarsasapogenin-β-D-
glucoside [M+H]
+
. The MS
2
 (m/z 579) fragmented to ions at m/z 435, 417, 399, 
273, and 255. The MS
3
 (m/z 579 → m/z 417) fragmented to an ion at m/z 273. The 
MS
3
 (m/z 579 → m/z 399) predominately fragmented to an ion at m/z 255 with 
lesser intensities of ions at m/z 381. The MS
3
 (m/z 579 → m/z 273) fragmented to 
an ion at m/z 255. The MS
3
 (m/z 579 → m/z 255) fragments to ions consistent 
with those observed in the MS
2
 (m/z 255) of sarsasapogenin, ie m/z 227, 213, 199, 
187, 185, 173, 159, 147, 145, and 133 ions.  
 The m/z 417 ion is attributed to the pseudo-molecular ion of sarsasapogenin, 
[sapogenin+H
+
], and is a result of the loss of a dehydrated glucose unit from 
sarsasapogenin-β-D-glucoside. The fragmentation characteristics of the m/z 417 
ion and other lower mass ions (Figure 4.24) were analogous to those observed for 
sarsasapogenin. 
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Figure 4.24. APCI fragmentation tree for sarsasapogenin-β-D-glucoside 
4.4.14 Fragmentation of Sarsasapogenin-β-D-galactoside (ESI and 
APCI) 
 The full scan ESI and APCI mass spectrum of sarsasapogenin-β-D-galactoside 
showed ions at m/z 579, 433, 417, 399, 273 and 255. These ions fragmented in an 
manner analogous to that above for sarsasapogenin-β-D-glucoside 
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The ESI and APCI fragmentation trees determined for sarsasapogenin-β-D-
galactoside are given in Figure 4.25 and 4.26 respectively. It was apparent that 
this fragmentation data could not be used to identify the structure of the glycoside 
residue, be it a glucosyl, galacosyl or another six carbon sugar residue. 
 
Figure 4.25. ESI fragmentation tree for sarsasapogenin-β-D-galactoside 
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Figure 4.26. APCI fragmentation tree for sarsasapogenin-β-D-galactoside 
4.4.15 Fragmentation of Episarsasapogenin, Tigogenin and Smilagenin 
(ESI and APCI) 
The fragmentation patterns of the structural isomers episarsasapogenin, tigogenin 
and smilagenin were investigated in the same manner as the model compounds 
previously described for both ESI and APCI interfaces. It was hoped that a 
difference in fragmentation characteristics may allow the distinction of one or 
more of episarsasapogenin, tigogenin and smilagenin from sarsasapogenin. 
  
Sarsasapogenin-
β,D-Galactoside 
m/z 417 
MS1 
 
MS2 
 
MS3 
 
m/z 399 
m/z 255 
 
m/z 399 
 
m/z 285 
 
m/z 381 
 m/z 285 
 m/z 255 
 
m/z 381 
 
m/z 213, 199, 
173,159, and 
147. 
 
m/z 579 
m/z 255 
 
m/z 273 
 
m/z 399 
 
m/z 417 
 
m/z 435 
 
m/z 255 
 
m/z 273 
 
m/z 225, 213, 
199, 173,159, 
147, 145, and 
133. 
 
m/z 273 
 
m/z 225, 213, 
199, 173,159, 
147, 145, and 
133. 
 
m/z 255 
 
m/z 285 
 
m/z 399 
 
m/z 417 
 
m/z 381 
 m/z 285 
 
m/z 273 
 m/z 255 
 
m/z 381 
 
m/z 285 
 
m/z 255 
 
m/z 273 
 
m/z 381 
 
m/z 285 
 
m/z 363 
 m/z 255 
 
m/z 225, 213, 199, 
173,159, 147, 145, 
and 133. 
 
  
8
9
 
 
Figure 4.27. ESI fragmentation tree for episarsasapogenin 
 
Figure 4.28. ESI fragmentation tree for tigogenin 
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Figure 4.29. ESI fragmentation tree for smilagenin 
 
Figure 4.30. APCI fragmentation tree for episarsasapogenin 
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Figure 4.31. APCI fragmentation tree for tigogenin 
 
Figure 4.32. APCI fragmentation tree for smilagenin 
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4.5 Mass Spectral Findings 
4.5.1 Established Mass Spectral Techniques for Isomeric 
Identification of Sapogenins 
Using EI- MS Blunden et al
26
 have reported that isomeric 3α/3β, 5α/5β, 25(R/S)-
sapogenin alcohols (smilagenin, sarsasapogenin, etc) can be distinguished by the 
ratios of three moderate intensity ions and their dehydration, namely the ratio of 
the m/z 302/284, m/z 287/269 and m/z 273/255 ion pairs observed in the EI mass 
spectra of parent alcohols
26
. 
Subsequently Wilkins et al
16
 found that isomeric 3α/3β, 5α/5β, 25(R/S)-sapogenin 
acetates could be distinguished in a like manner by consideration of m/z 284/344, 
m/z 329/269 and m/z 315/255 ion ratios observed for the isomeric acetates. Two 
advantages the use of acetates rather alcohols were (i) greater values for the ion 
ratios (especially so in the case of the range of values exhibited by m/z 284/344 
ratio) and (ii) amenability of the acetates to GC-MS analyses.  
A combination of ion ratio and GC capillary column retention time data, such as 
that reported by Meagher
25
 (Table 4.2), readily distinguishes isomeric acetates, 
and hence the sapogenins the acetates are derived from. The sharpness of the GC-
MS peaks (ca 0.1 min or less) enables the distinction of 25R- and 25S-isomers 
which typically eluted 0.4-0.5 min apart. 3α and 3β-acetylated sapogenins are also 
readily distinguished. 
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Table 4.2. GC-MS of sapogenin acetates 
 
Data taken from Meagher (1996)
25
. 
An objective of the investigations reported in this thesis was to determine if ESI 
or APCI full scan and MS
2
 mass data could, in a manner analogous that described 
above for EI-GC-MS data, determine the isomeric form of sapogenins. Such 
specificity would be utilised to distinguish free and conjugated sapogenins of the 
type expected to be present in rumen and other GI tract samples of animals 
grazing saponin containing plants implicated in the development of photo-
sensitisation diseases.  
4.5.2 Mass Spectral Techniques for Isomeric Identification by LC-
MS
n
 
The ESI and APCI LC-MS fragmentation trees were determined for smilagenin, 
episarsasapogenin, tigogenin and sarsasapogenin-β-D-galactoside under identical 
conditions to those utilised to determine the ESI and APCI LC-MS fragmentation 
trees for sarsasapogenin, diosgenin, and sarsasapogenin-β-D-glucoside (Section 
4.4). The mass spectral fragmentation characteristics established for the four 
sapogenin isomers showed no significant variation upon which distinction could 
be made between isomers or stereo-isomeric configurations. Likewise no 
RT
a
m/z  284 m/z  269 m/z  255
compound stereochemistry (min) m/z  344 m/z  329 m/z  315
smilagenin acetate 3β,5β,25R 16.87 2.92 0.74 0.9
sarsasapogenin acetate 3β,5β,25S 17.23 3.13 0.7 0.87
epismilagenin acetate 3α,5β,25R 17.19 7.89 0.8 1.3
episarsasapogenin acetate 3α,5β,25S 17.55 12.3 0.79 1.39
tigogenin acetate 3β,5α,25R 18.38 0.22 0.73 0.41
neotigogen acetate 3β,5α,25S 18.83 0.22 0.71 0.41
epitigogenin acetate 3α,5α,25R 17.25 0.31 0.76 0.67
epineotigogenin acetate 3α,5α,25S 17.64 0.3 0.8 0.64
a
RT =  Retention time (min) on a 25 m x 0.25 mm id HP-1 column.
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significant variation was observed between the Saponin isomers, sarsasapogenin-
β-D-glucoside and sarsasapogenin-β-D-galactoside. 
Only one significant ion pair of the type observed by Blunden
26
 in EI mass 
spectra, namely an m/z 273 ion and its m/z 255 dehydrated partner, was seen in the 
full scan, MS
2
 and/or MS
3
 ESI or APCI spectra of all of the sapogenins examined 
in this study. Due to the unpredictable nature observed for ESI and APCI 
interfaces in promoting consistent ionisation, monitoring of fragmentation in the 
ion trap was deemed more likely to give rise to consistent difference in ion ratio. 
However, for all the isomers investigated the relative intensities of the m/z 
273/255 ion ratios were similar and it was apparent that this data could not be 
used to deduce the C3, C-5 or C-25 stereochemistry of the investigated genins by 
LC-MS
n
. 
4.6 Chromatographic Properties 
4.6.1 The Need for Adequate Chromatographic Separation 
Ensuring adequate chromatographic peak separation of compounds/analytes that 
are indistinguishable from each other via their mass spectral fragmentation 
characteristics is highly desirable as it may be the only mechanism by which 
identification and quantification of a specific compound can be achieved.  
The GC-MS procedure described in Section 4.5.1 has been found to be capable of 
distinguishing the eight isomeric sapogenins listed in Table 4.2. Amongst the 
eight compounds listed in Table 4.2, only glucuronic acid conjugates of two of 
those compounds have been detected in crystalline biliary material recovered from 
sheep exhibiting hepatogenous photo-sensitisation disease symptoms. This 
demonstrates why the ability to distinguish between the isomers of the 
spirostanols is highly beneficial to the analysis of saponins associated with 
hepatogenous photo-sensitisation diseases of livestock. 
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The situation in respect of the chromatographic separation of the conjugated 
analogues (saponins) is more complicated than that of parent sapogenins in that 
numerous conjugated forms of a particular genin (eg mono-, di-, or 
triglycosylated) may exist. To date there is no report of an LC-MS procedure 
which can be used to distinguish the eight isomeric 3α/3β, 5α/5β, 25(R/S)-
sapogenins in either free or conjugated forms. Since the full scan MS and MS
n
 
data reported in Section 4.4 cannot be used to distinguish isomeric forms of a 
selection free and conjugated sapogenin the possibility that retention time data 
may be able to distinguish between isomers was investigated. 
4.6.2 Liquid Chromatographic Separation 
The retention times of sarsasapogenin, episarsasapogenin, tigogenin, smilagenin, 
sarsasapogenin-β-D-glucoside and sarsasapogenin-β-D-galactoside were analysed 
using a C-18 reverse phase column variety of column flow rates and choice of 
ACN-H2O gradient conditions. As noted in Section 3.2.4, the low water content of 
the ACN- H2O gradient mixtures required to elute isomeric sapogenins from the 
C-18 column utilised in the investigations reported in this thesis were not 
conducive to efficient ionisation of these compounds. 
Irrespective of the choice of gradient conditions and flow rates only small 
differences in retention times were observed for sarsasapogenin, 
episarsasapogenin, tigogenin, and smilagenin. In general such differences that 
were observed were less than the peak width of a target substance. Likewise 
sarsasapogenin-β-D-glucoside and sarsasapogenin-β-D-galactoside were also 
indistinguishable from each other based upon retention time data. 
As noted in above the low water content of the ACN-water gradient mixtures 
required to elute isomeric sapogenins from the C-18 column utilised in the 
investigations reported in this thesis were not conducive to efficient ionisation of 
these compounds, and in some cases retention time data was constrained by 
sensitivity limitations. 
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Some concern exists to whether the spirostanol sapogenins undergo structural 
modification in certain solutions analogus to those observed for furostanols as 
have been reported by other workers
34
. During the course of the retention time 
investigations multiple peaks had been observed in some chromatograms of aged 
solutions of spirostanols that had previously been as checked as isomerically pure 
by NMR and GC-MS (as described in Sections 4.2. and 4.3). The samples used in 
the above investigation into chromatographic separation were made up fresh in 
DCM/ACN to minimise any structural modification. 
4.6.3 Summary of LC-MSn Chromatographic Retention Findings 
It was apparent that while full scan and MS
2
 or MS
3
 LC-MS
n
 analyses can be used 
to identify the molecular weight of a conjugated sapogenins, and to demonstrate 
the sapogenin type nature of the genin component via its MS
n
 characteristics, LC-
MS retention time was not capable of distinguishing between isomeric sapogenins 
and saponins (at least under the conditions explored in this study). 
Accordingly, it can be concluded that where a knowledge of both the molecular 
weight of conjugated sapogenin constituents of rumen extracts and the structure of 
the genin component of a particular saponin is required, a combination of GC-MS 
and LC-MS
n
 data will be required. The isolation of a sufficient quantity of a target 
compound will be required to unequivocally identify its structure via detailed one 
and two-dimensional NMR analyses as neither LC-MS
n
 nor GC-MS are capable 
of unequivocal identification of an unknown structure. 
Increased LC resolution may enable identification of isomeric sapogenins and 
saponins. The application of UPLC column technology may improve separation 
of isomeric peaks for either saponins or sapogenins. UPLC columns possess 
smaller stationary phase particles (< 2 µm) and generate more effective separation 
(chromatographic resolution) than traditional HPLC columns utilising 5 µm 
stationary phase particles. 
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5 Summary, Conclusions and Recommendations for 
Further Work 
5.1 Overview of the Research 
As noted in Chapter 1, one of the principle objectives of the investigations 
reported in this thesis was to determine if LC-MS methods could be developed to 
identify free and conjugate sapogenins expected to be present in rumen and other 
GI tracts of susceptible and non-susceptible populations of sheep grazing saponin 
containing plants implicated in the development of photo-sensitisation.  
Depending on the progress and duration of a breeding programme currently 
underway in South America, it is envisaged that rumen and other GI tract samples 
from some sheep culled from the susceptible and non-susceptible groups will be 
available in 18-30 months. An objective of the collaborative research will be to 
identify free and conjugate sapogenins performed when the GI extract samples are 
available. The conjugated sapogenins expected may include glycosyl, 
glucuronide, sulphate, phosphate, fatty acid ester, or other conjugates. The 
detection of conjugated sapogenins present in the biological tissue would be 
beneficial to determining whether or not differences may exist in the absorption 
and transportation characteristics of specific ruminal metabolites of sapogenins. 
An example of particular interest is the metabolism of conjugated sapogenins in 
the liver where, in the case of animals suffering from hepatogenous photo-
sensitisation diseases, the deposition of calcium salts of epismilagenin and/or 
episarsasapogenin-β-D-glucuronides have been found in the bile ducts12-14. 
It is of note that episapogeninn-β-D-glucuronides conjugates have only been 
identified in liver samples recovered from susceptible sheep. It is not currently 
known if other conjugate sapogenin 'marker' substances (e.g. sulphate, phosphate, 
fatty acid, etc conjugates) are present other GI tract regions of affected sheep. LC-
MS analyses of the type described above may lead to the identification of such 
compounds amongst the level of unidentified conjugated sapogenins known to be 
present in GI tract samples of photo-sensitised livestock. 
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5.2 Significance of Ionisation Conditions, Eluent Composition 
and Flow Rate 
It is apparent for the investigations reported in this thesis that the sensitivity of 
LC-MS analyses can be substantially improved by careful attention to ionisation 
conditions such as; 
(i) eluent composition at the point of elution of a target analyte,  
(ii) eluent flow rate, and  
(iii)capillary temperature. 
Specifically it was found that there was a ca 2-20 fold increase in both APCI and 
ESI ion currents when the capillary interface temperature was maintained at 275-
300°C compared to than obtained at 200-225°C (Sections 3.2.5 and 3.3.4). It was 
also found that the water content of the ACN-H2O (0.01% formic acid) at the 
point of elution had a large effect upon the measured ion current, in the region of 
a 1-2 order of magnitude increase from 100% ACN (0.01% formic acid) to the 
optimal composition of eluent. 
While the use of a 150 mm x 2.00 mm 5 µm C-18 column resulted in it being 
possible to elute sarsasapogenin-β-D-glucoside and its galactoside analogue near 
optimal ACN-H2O, this was not the case for free sapogenins. The free sapogenins 
eluted when the water content of ACN-H2O (0.01% formic acid) was well below 
optimal for ionisation. It can be reasoned that the use that the use of shorter 
hydrocarbon chain length support (e.g. a C-8 rather than a C-18 column) would 
increase the LC-MS ion current and therefore sensitivity of sapogenin analyses by 
allowing the sapogenins to elute closer to optimal eluent compositions and flow 
rates based on the data presented in Section 3.2.4. Moreover it is apparent that the 
use of a lower flow rate, notwithstanding the any tendency towards broader peaks 
at lower rates also increases the sensitivity of both conjugated and free genin 
analyses 3-30 fold (Section 3.2.6). In combination these factors translate to ca 100 
fold increases in sensitivity relative to conditions that were believed to be 
appropriate prior to the investigations reported in this thesis. 
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 The significance of choosing elution conditions which maximise ionisation is 
demonstrated in Figure 5.1 and Figure 5.2 for chromatographic runs of 
sarsasapogenin-β-D-glucoside at four concentrations using ‘optimal’ ionisation 
conditions as defined in this thesis and ‘typical’ conditions commonly used prior 
to the investigations reported in this thesis. 
 The data presented in Figure 5.1 and Figure 5.2 shows that the optimised 
conditions can detect as little as 2.5*10
-9
 mol of sarsasapogenin-β-D-glucoside on 
the column, whereas the typical conditions did not detect the compound at 1*10
-8
 
mol.  
Figure 5.1 illustrates the dramatic increase in optimised ion currents and 
sensitivity for both m/z 579 [M+H]
+
 and TIC responses as a function of the nmol 
of injected sample. By comparison non optimised ion currents were not 
recognisable or quantifiable above baseline noise when plotted on the same scale 
(note non optimised m/z 579 [M+H]
+
 and TIC ion are overlapped in Figure 5.1). 
 
Figure 5.1. Comparison of optimal ionisation conditions and those 
commonly used prior to this investigation 
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Figure 5.2. Comparison of optimal ionisation conditions and those 
commonly used prior to this investigation 
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5.3 Recommendations for Further Work 
5.3.1 LC-MS Analysis 
As in earlier ovine studies, it is recommended that freeze dried GI tract samples 
should be sequential extracted with a non-polar solvent such as hexane or 
dichloromethane, and there after a moderately-polar solvent such as ethanol to 
afford free and conjugated extracts respectively. Precautions will need to be taken 
to avoid the use of solute conditions which cause the solute to be reactive towards 
the analytes. 
Since optimal eluent compositions and detector response for saponins and 
sapogenins differ maximum sensitivity will require the use of two sets of 
conditions: namely saponin optimised conditions and sapogenin optimised 
conditions.  
Saponins can be eluted during analysis of the sapogenins without causing any ill 
effects to the sapogenin analysis, however, to elute the sapogenins from the 
column used for saponins would significantly extend the duration of the 
chromatographic run and waste solvent. Removal of the saponins from the column 
between each analysis is desirable for repeatability of retention time data, and 
removal of possible interfering peaks in future runs. These negative effects are 
overcome by the application of the two step extraction process recommended 
above. 
Portions of the free and conjugated extracts should analysed by full scan positive 
ion ESI using C-8 and C-18 columns respectively, with the former likely to give 
the greatest response and acceptable retention times for sapogenins and the latter 
for conjugated analogues. LC-MS conditions, capillary temperature, eluent 
composition, ionisation agent, and flow rate, should be based on the optimised 
conditions discussed in Section 3.2. 
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Full scan LC-MS analyses should be supplemented by MS
2
 analyses of [M+H]
+
 
ions believed to be attributable to sapogenins and conjugated analogues. 
Therefore two or three MS
2
 events can be programmed per LC-MS while 
maintaining acceptable sensitivity. If a triple quad MS system is avaliable, MS
2
 
ion trap analyses should be supplemented by SRM analyses of [M+H]
+
 → m/z 
399, [M+H]
+
 → m/z 273, and [M+H]+ → m/z 255 transitions for sapogenins, and 
in addition [M+H]
+
 → m/z 417 for the saponins. Diosgenin and other spirosten-3-
ol analogues would require values 2 amu lower. 
5.3.2 Reducing Flow Rates by Application of low flow Columns 
Low flow rate, short 50 mm x 2.0 mm, 1.7 µm particle size micro UPLC columns 
are being used in place of higher flow rate, longer 100-150 mm x 2.4 mm (or even 
x 4.6 mm) 5 µm particle size conventional HPLC columns. It can be concluded 
from the data presented in Chapters 3 and 4 that provided column capacity is not a 
limiting factor, the use in future investigations of a 50 mm C-8 micro UPLC 
column will result an appreciable gain in sensitivity for sapogenin isomers 
compared to that which can be obtained using a conventional 150 mm C-18 
HPLC column. On the other hand it is likely a C-18 UPLC column would be more 
suited to glycosylated saponin analyses than a C-8 UPLC column. 
A further well documented benefit that would arise from the use of a micro UPLC 
rather than a micro HPLC column is sharper (narrower peaks). For a given peak 
area a 2-4 fold reduction in peak width is typically observed, leading to the ability 
to resolve peaks that may overlap using a conventional HPLC column
50, 51
. The 
increase in peak height associated with narrower peaks increases detection limits 
by increasing the concentration of the analytes in the eluent as the analyte peaks 
pass through the ionisation interface.  Peak overlapping was found to be a 
problem for the saponins sarsasapogenin-β-D-glucoside and sarsasapogenin-β-D-
galactoside in this investigation. UPLC columns may give the resolution required 
to separate these peaks. 
 103 
 
Notwithstanding the performance gains that might arise from the use of a C-8 
micro UPLC as opposed to a C-18 HPLC column, it is apparent that neither full 
scan or MS
2
/MS
3
 ESI or APCI ion ratio data can be used to establish the 
structures of isomeric free or conjugated sapogenins, in a manner similar to that 
which that which can be achieved for sapogenin acetates using EI-GC-MS. 
5.3.3 SRM Detection 
The principle advantage of ESI and APCI LC-MS methods is their ability to 
identify the molecular weight of a conjugated saponin metabolite, as illustrated in 
the present investigation for sarsasapogenin-β-D-glucoside and galactoside 
(Sections 4.4.12-4.4.14). The conjugated portion of such a metabolite can be 
recognised in full scan ESI or APCI spectra, followed by MS
2
 fragmentation 
(30% collision energy) of the parent [M+H]
+
 ion to afford ions attributable to m/z 
417 (protonated genin) and/or m/z 399 ions and a number of other distinctive 
fragment ions, including m/z 273 and 255 ions for spirostan-3-ols (Sections 
4.4.12-4.4.14). 
Rumen and other GI tract samples typically contain complex series of free and 
conjugated sapogenin and other metabolites, including steroidal plant compounds 
such as b-sitosterol, stigmasterol, cholesterol, bile acids, and other lipids such as 
triglycerides, fatty acids, etc. EI-GC-MS methods for the identification of 
sapogenins have utilised selected ion mode (SIM) detection of the universally 
present m/z 139 ion, aided by the analyses of the ratio of three lower intensity 
pairs of ions (Section 4.5.1). In the case of ion trap or triple quad based LC-MS 
analyses selectivity can be achieved using SRM (MS
2
) based detection. 
In the case of sapogenins (spirostan-3-ol type), suitable SRM parent-daughter ion 
transitions are m/z 417 → m/z 399, m/z 417 → m/z 273, and m/z 417 → m/z 255, 
or the corresponding [M+H]
+
 → m/z 417, [M+H]+ → m/z 399, [M+H]+ → m/z 
273, and [M+H]
+
 → m/z 255 transitions in the case of conjugated sapogenins. 
Substantially greater sensitivity would be observed using a triple quad MS 
systems as opposed to an ion trap MS since a triple quad system can continuously 
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monitor specified transitions whereas the sensitivity of an ion trap system is 
constrained by the time required to load ions generated in the MS source into the 
trap, expel non target ions, fragment the target ion, expel non target MS
2
 ions and 
record only the target SRM daughter ion.  
 If required MS
3
 fragmentation to either the m/z 273 or 255 ions can be used to 
confirm the origin of these ions are from free or conjugate spirostanol containing 
precursor molecules (see for example fragmentation trees represented in Sections 
4.4 from sarsasapogenin and sarsasapogenin-β-D-glucoside). 
5.3.4 Superiority of ESI Detection 
The use of an ESI interface was found to be superior to be use of an APCI 
interface, at least when using the Department's LCQ MS system on standard 
solutions. Under APCI conditions a greater degree of fragmentation was observed 
in full scan MS, presumably due to increased thermal fragment during the passage 
of analytes through the flash vapour stage of the APCI inlet. Full scan APCI ion 
currents were typically two to tenfold lower than ESI ion currents for the model 
compounds. 
5.3.5 Compensating for Signal Suppression 
It is envisaged that signal suppression will be of huge significance for the accurate 
quantification and even identification of saponins and sapogenins extracted from 
the GI tract of photo-sensitised sheep. ESI, the preferred ionisation interface for 
the analysis of saponins, as determined by this investigation, is prone to strong 
signal suppression by components in the matrix at the time of ionisation. To 
overcome the restrictions that can be induced by signal suppression careful 
method development that minimises its effect needs to be conducted. Factors to be 
investigated include; 
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(i) Sample extraction processes with preferable methods being those that 
would extract the analytes without many of the offending signal 
suppressing compounds. 
(ii) The region in which signal suppressing compounds elute, with a view to 
manipulating LC conditions so they don’t co-elute with the analytes. 
(iii) Inclusion of appropriate internal standards for quantification of the extent 
signal suppression excerts upon the analytes. 
 
Prior to LC-MS or GC-MS analyses there may be a requirement to clean up 
samples, options include using short C-18 or sep-pak or GPC type columns. Sep-
pak or GPC type columns can be used to remove earlier eluting highly polar 
and/or later eluting non polar compounds from sapogenin and saponin containing 
extracts. 
Based upon the fragmentation characteristics of 2,2,4,4-
2
H4-episarsasapogenin 
and 2,2,4,4-
2
H4-sarsasapogenin, introduction of deuterium at the C-2 and C-4 
positions, as synthesised by loader et al
46
, would be highly suitable choices as 
internal standards for sapogenin and saponin quantification by LC-MS
n
. The 
20,23,23-
2
H3-sapogenin/saponin analogues are not considered as suitable due to 
the tendency to back exchange deuterium with protic solvents
52
.  
5.3.6 Requirement for Complementary GC-MS analysis 
GC-MS methodology has been tried and tested and found to give accurate 
quantitative data for the analysis of derivatised genins. Any method developed for 
LC-MS detection of the genins should have the results directly compared to 
results obtained for the existing GC-MS methodology to ascertain the accuracy 
using the newly developed LC-MS methodology. The GC-MS analysis should be 
performed on portions of both the free and hydrolysed conjugate extracts as per 
the Wilkins et al method
16
.  
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While full scan and SRM ESI/APCI-MS data can be used to define the molecular 
weight of a parent saponins and its genin component, it does not specificially 
define the structure of the genin, be it smilagenin, epismilagenin, sarsasapogenin, 
episarsasapogenin, etc. Some identification can be achieved by comparing 
chromatographic retention times, but this in itself does not provide unequivocal 
identification as many isomers may have indistinguisable retention times. To this 
end there remains a requirement to hydrolyse conjugated saponin containing 
extracts and analyse a subsample of the acetylated free genins using GC-MS 
protocols
16
. Once the saponins are partially identified by GC-MS techniques it 
may be possible to assign the sapogenin content of saponins by comparison of 
GC-MS and LC-MS spectra. 
5.3.7 Requirement for Isolation, and Structural Determination via 
NMR and HRMS 
Since MS data alone cannot be used to identify the gross structure of conjugated 
sapogenins, there will be a need to isolate sufficient quantities of metabolites 
which have not been formally characterised using one and two dimensional NMR 
methods. Molecular weights will need to be established using high resolution MS 
data, especially if it transpires that susceptible sheep are characterised by the 
presence of a different series of conjugated metabolites in one or more of the GI 
tract regions. 
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5.4 Conclusions 
Based on the large increase in ionisation efficiency obtained in this investigation it 
is anticipated LC-MS
n
 determination of the saponins implicated in hepatogenous 
photo-sensitisation of livestock should be achievable on the University of 
Waikato’s LC-MSn system. 
This investigation has also shown some of the limitations in current LC-MS
n
 
analysis including the inability to distinguish many structural isomers. Importantly 
MS
n
 data can be used to determine the mass of a saponin, along with the mass of 
the glycoside and sapogenin portions of the saponin. 
Quantification of the saponins should be achievable via LC-MS
n
 but will require 
careful and precise method development to minimise the significance of signal 
suppression effects (matrix effects).  
LC-MS
n
 data should complement the current GC-MS methodology and contribute 
to an improved understanding of the ruminal metabolism of saponins in animals 
suffering from hepatogenous photo-sensitisation diseases. 
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